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Abstract
Interval-censored time-to-event data occur naturally in studies of diseases where the
symptoms are not directly observable, and periodic lab or clinical examinations are required for detection. Due to the lack of well-established procedures, interval-censored
data have been conventionally treated as right-censored data, however, this introduces bias at the first place. This dissertation focuses on methodological research
and software development for interval-censored data. Specifically, it consists of three
projects. The first project is to create an R package for regression analysis and survival curve estimation of interval-censored data based on several published papers
by our research team. In the second project, a Bayesian semiparametric proportional hazards model with spatial random effect is developed for spatially correlated
interval-censored data. In the third project, we propose a multivariate frailty model
for clustered interval-censored failure times, which is analogous to a mixed model in
regression analysis.
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Chapter 1
Introduction
1.1

Interval-Censoring

Interval-censored data occur naturally in studies of diseases where the symptoms
of interest are not directly observable, and laboratrory or clinical examinations are
required for detection. The exact time to event of interest T is not directly observed,
but is known to fall within a time interval (L, R], such that 0 ≤ L < T ≤ R ≤ ∞.
Consider in a tumorigenicity study, a lab animal has to be dissected to check
whether a tumor has developed. Let C denote the time of dissection, and T denote
the true tumor onset time, then the data observed is (C, 1(T ≤ C)). Then



 (0, C], T ≤ C

(L, R] = 


 (C, ∞), T > C

(1.1)

This is called case 1 interval-censored or current status data.
Suppose there are two examination times U and V for each subject, then the data
observed is (U, V, δ1 = I(T ≤ U ), δ2 = I(U < T ≤ V )). Then




(0, U ],





(L, R] =  (U, V ],






 (V, ∞),

T ≤U
U <T ≤V

(1.2)

T >C

This is the case 2 interval-censored data. Case k interval-censoring refers to when
there are k examination times per subject.
Consider another situation. In an oncology clinical trial for non-small cell lung
cancer, the endpoint of interest is progression-free survival (PFS). The patients are
1

scanned by CT every couple of weeks for evaluation of tumor sizes and new lesions.
Then the scan results are read by a diagnostic radiologist to determine if progression
has occurred or not. Then PFS is interval-censored as the exact time to progression
is not observed but is known to fall within a time interval (L, R]. Suppose Oi =
{Oi1 , . . . , Oi,ni } are the examination times for the ith patient, i = 1, . . . , n. Then

(L, R] =





(0, Oi,1 ],





T ≤ Oi,1

(Oi,L , Oi,R ], Oi,L < T ≤ Oi,R






 (Oi,ni , ∞), T > Oi,ni

(1.3)

This is called general interval-censoring, which includes case 1, case 2 and case k
interval-censoring as special cases. In the dissertation, we will focus on general
interval-censoring.

1.2

Likelihood function

Throughout the dissertation, we assume the following two basic assumptions (Huang
and Wellner, 1997). (A1) The failure time is independent of the examinations times
given the covariates. (A2) The distribution of the examination times does not involve
the parameters of interest.
Under these assumptions we can derive the likelihood function. For case 1, or
equivalently current status data, the joint density of a single observation (C, δ =
I(T ≤ C), x) is:
f (δ, c, x) = f (δ|c, x)f (c, x) = f (δ|x)f (c, x)
= F (c|x)δ (1 − F (c|x)1−δ f (c, x)),
where F is the cdf of T . So for an independent sample of size n from the same
distribution, the likelihood function is proportional to:
L=

n n
Y

o

F (ci |xi )(1 − F (ci |xi ))1−δi .

i=1

2

For case 2 and general interval-censoring, let δ1 , δ2 , δ3 denote left-, interval-, and
right-censoring, the joint density of a single observation (δ1 , δ2 , δ3 , L, R, x) is:
f (δ1 , δ2 , δ3 , L, R, x) = f (δ1 , δ2 , δ3 |L, R, x)f (L, R, x) = f (δ1 , δ2 , δ3 |x)f (L, R, x)
= F (R|x)δ1 (F (R|x) − F (L|x))δ2 (1 − F (L|x))δ3 f (L, R, x).
The likelihood function for an independent sample of size n from the same distribution
is proportional to:
L=

n n
Y

o

F (Ri |xi )δ1i (F (Ri |xi ) − F (Li |xi ))δ2i (1 − F (Li |xi ))δ3i .

i=1

1.3

Motivations

For interval-censored data, the conventional approach in pharmaceutical industry
treats the right-point of the time interval as the observed time, and then apply the
standard right-censored methods. However, this approach can lead to biased estimation and invalid inferences (Rücker and Messerer, 1988; Odell et al., 1992; Lindsey
and Ryan, 1998; Sun and Chen, 2012). Better estimations can be obtained if the
information of interval censorship is taken into account in modeling.
Quite a few new methods for analysis of interval-censored time-to-event data have
been proposed in the last two decades. However, most of these methods either rely
on parametric assumptions that are hard to verify in practice or are computationally
challenging. As a result, none of them has been accepted by the pharmaceutical
industry as a standard procedure. We propose to model the survival function semiparametically through I-splines (Ramsay, 1988) and estimate survival function and
regression coefficients through Markov chain Monte Carlo (MCMC) algorithm. Our
models are relatively straightforward to implement in practice and give more accurate
estimates. Specifically, the dissertation research consists of three projects; each has
been initiated to address certain problems as specified below.

3

Currently, a few packages and SAS macros, mainly the ‘interval’ and ‘glrt’ packages in R and the %EMICM and the %ICSTEST macros in SAS, have been developed
to provide estimation and comparison for survival functions for interval-censored data.
However, there are currently few options available for fitting regression models, except
the ‘survBayes’ package and the ‘intcox’ package. As the first project of this dissertation, we have built an R package, ICBayes, which fits proportional hazards (PH),
proportional odds (PO), and probit regression models from a Bayesian perspective.
It is possible that failure times of interest are both interval-censored and spatially
correlated. For instance, in a lung cancer clinical trial, patients are recruited from
a number of regions where air quality in a region is similar to that in its neighbors
but might differ substantially from that in the other regions. If air quality exerts
an effect on treatment outcome, then survival times of patients may be spatially
correlated. Only one spatial frailty model has been developed for such type of data
under parametric Weibull PH cure rate model (Banerjee and Carlin, 2004). We
propose a semiparametric spatial frailty PH model, which provides greater flexibility
for modeling failure time.
Clustered interval-censored survival data can easily occur in multicenter clinical
trials for cancer, HIV, or other infectious diseases. Tumor progression, HIV progression to AIDS, and presence/absence of an infection normally all need periodic lab
examinations for detection. Characteristics that vary by center may affect survival
times, which implies either an overall frailty to account for baseline hazard heterogeneity across centers or a frailty corresponding to a certain predictor to account for
center-wise variation of this predictor’s effect. We propose to model the variance of a
potential frailty with a mixture of point mass and gamma distribution, because rather
than arbitrarily assuming the heterogeneity structure, we want to actually estimate
the probability that a frailty exists.

4

Chapter 2
Background Knowledge
2.1

The Poisson Distribution and the Poisson Process

2.1.1 Additive Property of Poisson Distribution Suppose X1 , . . . , Xn are independent with Xi ∼ Poisson(λi ), i = 1, . . . , n, then

Yi =

n
X

n
X

Xi ∼ Poisson(

λi ).

i=1

i=1

This can be proved through the moment generating function method. This property
will be used in introducing Poisson latent variables in our data augmentation.
2.1.2 Poisson Process A Poisson process is a counting process in which events
occur continuously and independently of one another. Let N (t) be the number of
events in time interval (0, t]. The process {N (t), t ≥ 0} is said to be a Poisson process
with rate (or intensity) λ, λ > 0, if
• N (0) = 0.
• (independent increment) the number of events in non-overlapping intervals are
independent.
• (stationary increment) the number of events in a time interval depends only on
the length of the interval.
= λ.
• limh→0 P (N (h)=1)
h
= 0.
• limh→0 P (N (h)≥2)
h

5

Some useful properties of Poisson process are:
• The number of events in an interval of length t is a Poisson random variable
with mean λt.
• The interarrival times are independent exp(λ) random variables.
• The time of the nth event is Gamma(n, λ) random variable, where λ is the rate
parameter.
2.1.3 Nonhomogeneous Poisson Process A nonhomogeneous Poisson process
relaxes the stationarity assumption of a Poisson process. A process {N (t), t >= 0}
is a nonhomogeneous Poisson process with rate (intensity) λ(t), t ≥ 0, if
• N (0) = 0.
• (independent increment) the number of events in non-overlapping intervals are
independent.
(t)=1)
= λ(t).
• limh→0 P (N (t+h)−N
h
(t)≥2)
• limh→0 P (N (t+h)−N
= 0.
h

The mean-value function (cumulative intensity function) is defined as:
m(t) =

Z

0

t

λ(s)ds,

t ≥ 0.

Some useful properties of a nonhomogeneous Poisson process are:
• For t > 0, N (t) ∼ Poisson(m(t)).
• N (t + h) − N (t) ∼ Poisson(m(t + h) − m(t)).
• For each 0 ≤ t1 < t2 < . . . < tm , N (t1 ), N (t2 ) − N (t1 ), . . . , N (tm ) − N (tm−1 )
are independent Poisson random variables.

6

• Let Sn be the time of the nth occurrence, then P {Sn > t} = P {N (t) < n} =
Pn−1
j=0

e−m(t) (m(t))j
.
j!

This property will be particularly used to derive data aug-

mentation in our models.

The relationship between Poisson process and nonhomogeneous Poisson process
can be illustrated as follows. Suppose that events are occurring according to a Poisson
process with rate λ, and the probability that an event at time t is counted is p(t).
Then the process of counted events constitutes a nonhomogeneous Poissson process
with rate λ(t) = λ · p(t).

2.2

Monte Carlo Markov Chain Methods

2.2.1 Markov Chains A Markov chain is a stochastic process in which the next
state depends only on the current state. This memoryless characteristic is called the
Markov property. In mathematical form, consider a draw θ(t) at iteration t, then the
next draw θ(t+1) at iteration t + 1 only depends on the current draw θ(t) , and not on
any past draws. So the draws in a Markov chain are slightly dependent.
Suppose we have a target distribution f (θ) and we want to estimate E(g(θ)), where
g() is some function. Instead of solving it analytically as I =

R

S

g(θ)f (θ)dθ, where S is

the parameter space (state space). We can approximate the integral via Monte Carlo
integration by simulating M values from f (θ) and calculating Ib =

1
M

PM

t=1

g(θ(t) ). If

the M values are independent, then by Strong Law of Large Numbers (SLLN), Ib is a

consistent estimator of I. The Markov analog to the SLLN is the Ergodic Theorem.
It is the reason why Markov chain Monte Carlo methods works: it allows us to use a
sample path from a Markov chain to estimate various quantities of interest.
For a discrete Markov chain, it is defined to be irreducible if all its states communicate. A state i is recurrent if E(Vi |θ(0) = i) = ∞, where Vi is the number of visits
in state i. Most MCMC methods are based on general state space Markov chains.
Here we give the definition of irreducibility and recurrence for them.
7

Definition 1 (Irreducibility). Given a distribution µ on the state space S, a
Markov chain is said to be f -irreducible if for all sets A with f (A) > 0 and for all
x ∈ S, there exists an m ∈ N0 such that
P (θ(t+m) ∈ A|θ(t) = x) =

Z

A

K (m) (x, y)dy > 0,

where K (m) (x, y) is the m-step transition kernel.
Definition 2 (Recurrence). A set A ⊂ S is said to be recurrent for a Markov
chain θ if for all x ∈ A
E(VA |θ(0) = x) = ∞.
And a Markov chain is said to be recurrent if
i. The chain is irreducible.
ii. Every measurable set with f (A) > 0 is recurrent.
Theorem 1 (Ergodic Theorem). Let θ be a f -irreducible, recurrent Rd -valued
Markov chain with stationary distribution f . Then for any integrable function g :
Rd → R, we have
limM →∞

Z
M
1 X
g(θ(t) ) → g(θ)f (θ)dθ,
M t=1
S

with probability 1 for almost every starting value θ(0) . If θ is Harris-recurrent, then
this holds for every starting value θ(0) .
A MCMC method for the simulation of a distribution f is any method producing
an ergodic Markov chain (θ(t) ) whose stationary distribution is f . The two most
commonly used MCMC algorithms are the Metropolis-Hastings algorithm and the
Gibbs sampler.
2.2.2 Metropolis-Hastings Algorithm The Metropolis-Hastings algorithm enables generating random numbers from a probability distribution f without directly
sampling from it. It constructs an ergodic Markov chain that satisfies the detailed
balance property with respect to f , as shown in the following.
8

The transition kernel K is based on a proposal distribution q(θ|θ(t) ). Specifically,
given the current state θ(t) , we generate a candidate value θ′ ∼ q(θ|θ(t) ), and set the
next state θ(t+1) as:
θ

(t+1)




 θ′ ,

=


 θ (t) ,

′

(t)

′

|θ )
w.p. a(θ(t) , θ′ ) = min(1, ff(θ(θ(t))q(θ
)
)q(θ′ |θ(t) )
(t)

(2.1)

′

w.p. 1 − a(θ , θ )

This leads to the following transition kernel
K(θ(t) , θ(t+1) ) = q(θ(t+1) |θ(t) )a(θ(t) , θ(t+1) ) + (1 −

X

a(θ(t) , θ′ )q(θ′ |θ(t) ))δθ(t) (θ(t+1) ).

θ′

It is straightforward to show that the two additive items in the equation above satisfy
the detailed balance condition, so K is in detailed balance with respect to f :
K(θ(t−1) , θ(t) )f (θ(t−1) ) = K(θ(t) , θ(t−1) )f (θ(t) ).
Thus f is the stationary distribution of the Markov chain (θ(0) , θ(1) , . . .). Furthermore, if q(θ|θ(t) ) > 0 for all θ,

θ(t) ∈ S, then the Makov chain is irreducible. And

since the chain is Harris recurrent if it is irreducible (Tieney, 1994), then it is Ergodic.
2.2.3 Gibbs Sampler Suppose we have a joint distribution f (θ1 , θ2 , . . . , θk ) that
we want to sample from. We can use the Gibbs sampler (Geman and Geman, 1984)
to sample from it if we know the full conditional distributions for each parameter.
The full conditional distribution, f (θj |θ−j , y), is the distribution of the parameter
conditional on data and all the other parameters.
The Gibbs sampler iterates through the following steps:
i Start with initial values θ(0) .
(1)

(0)

(1)

(1)

(0)

ii Draw a value θ1 from its full conditional distribution f (θ1 |θ2 , . . . , θk , y).
(0)

(0)

iii Draw a value θ2 from its full conditional distribution f (θ2 |θ1 , θ3 , . . . , θk , y).
iv Continue for θ3 , . . . , θk . Then we get the first draw θ (1) .
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v Repeat steps ii-iv for M iterations.
Then we get the Markov chain (θ (0) , θ (1) , . . . , θ (M ) ).
The Hammersley-Clifford Theorem (Robert and Casella, 1999, p298) proved that
if (θ1 , θ2 , . . . , θk ) satisfy the positivity condition and have joint density, then the full
conditionals fully specify the joint distribution. It can be shown that f (θ1 , θ2 , . . . , θk )
is the invariant distribution of the Markov chain (θ (0) , θ (1) , . . .) generated by the Gibbs
sampler. Also, if the joint density f (θ1 , θ2 , . . . , θk ) satisfies the positivity condition,
then the Gibbs sampler yields an irreducible, recurrent Markov chain. Hence the
chain is ergodic.
Definition 3 (Positivity condition). Random variables (X1 , . . . , Xn ) with joint
density f (x1 , . . . , xn ) and marginal densities fXi (xi ) is said to satisfy the positivity
condition if fXi (xi ) > 0 for all i = 1, . . . , n implies f (x1 , . . . , xn ) > 0.
2.3

I-Splines

2.3.1 Splines A spline function f is a piecewise polynomial function defined on an
interval [xmin , xmax ] with specified continuity constraint. The interval is subdivided
by a mesh of points xmin = ξ1 < . . . < ξq = xmax , and within each subinterval
[ξj , ξj+1 ) is a polynomial Pj of order k.
Let n denote the number of free parameters that specify the spline function. A
knot sequence t = {t1 , . . . , tn+k } is derived by placing knots at boundary values ξi
according to the order of continuity at that boundary. The simplest case is to put
a single knot at each boundary value, which implies that the order of continuity is
(k − 1) and that (k − 2) derivatives match at boundary points ξi . So the knots are
t1 = . . . = tk = xmin , tk+1 = ξ2 , . . ., tn+1 = . . . = tn+k = xmax . Under this simplest
case, the number of free parameters n equals the number of interior knots plus the
order k.
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2.3.2 M-Splines With a suitable set of basis splines, for instance, the M-spline
family Mi (x|k, t), we can construct a spline f as a linear combination:
n
X

f=

a i Mi .

i=1

A set of M-splines can be defined by the following recursions:
For k = 1, Mi (x|k = 1, t) =
For k > 1, Mi (x|k, t) =

1
;
ti+1 −ti

0 otherwise.

k[(x−ti )Mi (x|k−1,t)+(ti+k −x)Mi+1 (x|k−1,t)]
.
(k−1)(ti+k −ti )

As we can see, Mi (x|k, t) > 0 only if ti ≤ x ≤ ti+k . It is an important property,
as it implies that the coefficient ai will only affect f within this subinterval. Other
useful properties include: 1) Mi ≥ 0; 2) Mi integrates to 1; 3) Mi has k −2 continuous
derivatives at interior knots.
Figure 2.1 shows an M-spline of order 3 on the interval [0,1], with three interior
knots at 0.3, 0.5, 0.6, and a spline based on the M-splines.
2.3.3 I-Splines Because M-splines are nonnegative, monotone splines can be
derived based on them using integration:
Ii (x|k, t) =

Z

x

xmin

Mi (u|k, t)du.

This is called I-splines. Each Ii is a piecewise polynomial of degree k (order k), since
each Mi is a piecewise polynomial of degree k − 1 (order k).
For a simple knot sequence, an I-spline Ii of order k can be expressed in terms of
the M-splines Mi of order k + 1:





0, i > j




P
Ii (x|k, t) =  jm=i (tm+k+1 − tm )Mm (x|k + 1, t)/(k + 1),





 1, i < j − k + 1.

j−k+1≤i≤j

(2.2)

Figure 2.2 shows the I-splines that were derived from the M-splines above, and a
monotone spline based on the I-splines.
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t
Figure 2.1 A set of M-splines with order = 3, t = {0, 0.3, 0.5, 0.6, 1}, and
f = 1.2M1 + 2.0M2 + 1.2M3 + 1.2M4 + 3.0M5 + 0.0M6

12

1.5
1.0
0.0

0.5

I−splines

0.0

0.2

0.4

0.6

0.8

1.0

t
Figure 2.2 A set of I-splines with order = 3, t = {0, 0.3, 0.5, 0.6, 1}, and
f = (1.2I1 + 2.0I2 + 1.2I3 + 1.2I4 + 3.0I5 + 0.0I6 )/6
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Chapter 3
ICBayes: An R Package for Modeling
Interval-Censored Data
3.1

Introduction

In clinical trials and medical studies, there are often times where the event of interest
is not directly observable and patients are examined periodically for disease occurrence or progression. In such situations, each individual is checked at a sequence
of times and the exact survival time is only known to fall within a time interval
(L, R]. This time to event is known to be interval-censored (Peto, 1973; Odell et
al., 1992; Gentleman and Geyer, 1994). A special case of general interval-censored
data is case 1 interval-censored data or equivalently referred to as current status data
(Schick and Yu, 2000), where the event of interest is not directly observable and each
subject in the study has only one observation time, and hence the failure times are
either left-censored or right-censored. Case 1 interval-censored data often occur in
tumorigenicity studies where lab animals are sacrificed to see if a certain tumor has
developed or not. Three major statistical problems in survival analysis are estimation of survival function, k-sample survival comparison, and estimation of regression
coefficients from censored data.
In the past two decades, many new methods have been developed for the analysis
of interval-censored data. The survival function for interval-censored data is normally
estimated through a classic nonparametric maximum likelihood procedure based on
Peto (1973). In his paper, Peto developed a nonparametric method to find the empir-
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ical survival curve that maximized the overall likelihood for interval-censored data.
Based on observed intervals, a set of distinct intervals was defined. He proved that
the likelihood is a function of the magnitude of the decrease of the survival function
in these intervals only, and the empirical survival curve should be flat everywhere
else. He described a constrained Newton-Raphson algorithm to search for the nonparametric maximum likelihood estimator (NPMLE). Turnbull (1976) proved that
the NPMLE could be found by solving a self-consistency equation. This equation
can be solved using the EM algorithm (Dempster, Laird, and Rubin, 1977) with the
method of Gentleman and Geyer (1994) to ensure global maximum. Later, more
efficient algorithms were proposed, for examples, iterative convex minorant (ICM) by
Groeneboom and Wellner (1992) and EM iterative convex minorant (EM-ICM) by
Wellner and Zhan (1997).
Most of the research on interval-censored data has been focused on subgroup survival comparison. Finkelstein (1986) developed a method for fitting the proportional
hazards (PH) model (Cox, 1972) for interval-censored data. The likelihood is written
as a function of regression parameters and nuisance parameters that are transformations of baseline survival at distinct time points. Regression coefficients are estimated
by the maximum likelihood method and covariance matrix of estimators is estimated
by Fisher information. One drawback of this classic method is that the number of
nuisance parameters increases as sample size increases and nuisance parameters often
approach the boundary of the constrained parameter space, which violates the regularity conditions of maximum likelihood. To avoid the boundary problem associated
with likelihood-based tests (e.g., score test, Wald test, and likelihood ratio test) for
comparing survival functions, Fay (1996) developed a permutational variance for the
score statistic, which requires that censoring is independent of covariates. Also he
proposed grouping data to reduce the number of nuisance parameters, such that none
of the estimates would approach the parameter space boundary. The methods in Fay
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(1996) only consider treatments as covariates and are only able to provide hypothesis
testing but not point estimation. Sun (1996) developed a nonparametric test for comparing subgroup survival distributions by assuming that failure time is discrete. Zhao
and Sun (2004) presented a generalized log-rank test of subgroup survival function
comparison for interval-censored data. The test statistic is constructed nonparametrically and its covariance matrix is estimated based on Rubin’s multiple imputation.
Sun et al. (2005) proposed a new class of nonparametric generalized log-rank tests
for k-sample comparison problem of interval-censored data, and also established the
asymptotic distribution of the test statistic. Zhao et al. (2008) presented a class of
generalized log-rank tests for partly interval-censored data that include both exact
and interval-censored observations, and established their asymptotic properties.
To provide point estimation of treatment effects while controlling for relevant covariates, a regression model is needed. Most regression methods for interval-censored
data have been developed under the proportional hazards model, with the first one being Finkelstein (1986). Pan (1999) extended the ICM algorithm, originally developed
to compute the NPMLE of survival function, to the PH model for interval-censored
data. Compared to the Newton-Raphson iteration suggested in Finkelstein (1986),
Pan (1999) used ICM to obtain the MLEs of regression coefficients and baseline survival function. A bootstrap method was applied to estimate standard errors of MLEs
of regression coefficients. Recently splines have been used to model baseline hazard
function. For instance, Cai and Betensky (2003) modeled the logarithm of baseline
hazard function with a linear spline mixed model. Their method produces estimation for regression coefficients and baseline hazard. The covariance matrix of the
estimators is obtained through the sandwich method.
Currently, a few R packages and SAS macros have been developed for analyzing
interval-censored data. The ‘interval’ package in R provides the NPMLE of survival
function for different subgroups using the EM algorithm and the Gentleman and
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Geyer (1994) algorithm, and performs several tests for k-sample comparison based
on Sun (1996), Finkelstein (1986), and Fay (1996). The ‘glrt’ package in R includes
functions to perform three generalized logrank tests based on Zhao and Sun (2004),
Sun, Zhao, and Zhao (2005), Zhao, Zhao, Sun, and Kim (2008), and Finkelstein’s
score test. The SAS macro %EMICM uses the EM-ICM algorithm by Wellner and
Zhan (1997) to compute the NPMLE of the survival functions for different groups
and %ICTEST applies the nonparametric tests developed in Zhao and Sun (2004)
and Sun, Zhao, and Zhao (2005). The only software packages available for regression analysis are the two R packages ‘intcox’ and ‘survBayes’. The ‘intcox’ package
gives point estimate for a regression coefficient and estimation for baseline survival
curve. However, a bootstrap method is needed to estimate the standard errors of
point estimates. The ‘survBayes’ package gives regression coefficient estimation and
baseline survival curve estimaiton, based on a Bayesian approach. We have recently
proposed approaches to fit proportional hazards model, proportional odds model, and
probit model for interval-censored data (Lin and Wang, 2009; Cai et al., 2011; Wang
and Lin, 2011; Lin et al., 2013). The R package ‘ICBayes’ is created based on these
models for estimating survival functions and regression coefficients.

3.2

Models Included in the Package

We have included four models in our package for either case 1 or general intervalcensored failure time data. The common parts of our methods are: (1) we used a
monotone spline based on a set of I-splines to provide a smooth estimation for survival function; (2) we developed our posteriors through different data augmentations.
(3) The MCMC algorithms we proposed are relatively straightforward to implement
since most posterior distributions are of standard forms. In the following, we briefly
describe the data and model form, spline approximation, data augmentation, and
MCMC sampling for each of our models.
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3.2.1 Proportional Hazards Model for Case 1 Interval-Censored Data
For the ith subject in study, let Ti denote the failure time of interest, Ci denote the
observation time, and δi indicate left-censoring, i = 1, . . . , n. Also let x be the vector
of covariates, and β be the vector of regression coefficients. Under the PH model
λ(t|x) = λ0 (t)exp(β ′ x), Cai et al. (2012) proposed to model the baseline cumulative
hazard function with a linear combination of monotone splines (Ramsay, 1988):
K
X

Λ0 (t) =

γl bl (t),

(3.1)

l=1

where {bl } is a set of I-splines, each of which is nondecreasing from 0 to 1, and {γl } is a
set of nonnegative coefficients. As we have noted in Chapter 2, the set of I-splines are
determined by specifying the placement of knots and the order of the I-splines. The
number of I-splines K equals the number of interior knots plus the order (Ramsay,
1988).
To facilitate posterior computation, data augmentation with Poisson latent variables is employed. Redefine left-censoring indicator as δi = I(Zi > 0), where latent
variable Zi ∼ Poisson(λ0 (ci )exp(β ′ xi )). Furthermore, based on the additive property
of Poisson distribution and the form of (3.1), import mutually independent latent
variables Zil such that Zi =

Pk

l=1

Zil and Zil ∼ Poisson(γl bl (ci )exp(β ′ xi )). Then the

augmented data likelihood in terms of the latent variables is as follows:
L=

"K
n
Y
Y

i=1 l=1

x′i β

Poi(Zil |γl bl (ci )e

#

) [I(Zi > 0)]δi [I(Zi = 0)]1−δi .

This is a product of Poisson functions, which allows relatively straightforward derivation of posteriors.
In the Gibbs sampler, the full conditional distributions of the latent variables {Zi }
and {Zil }, and the coefficients {γl } are all of standard forms. The full conditional
distributions of regression coefficients βr , r = 1, . . . , p, are not standard and are
sampled using adaptive rejection Metropolis sampling (ARMS) algorithm (Gilks et
al., 1995). For more details, please refer to Cai et al. (2012).
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3.2.2 Proportional Hazards Model for General Interval-Censored Data
For subject i in a study, let (Li , Ri ] denote the observed interval, δi1 , δi2 , δi3 be left, interval-, and right-censoring indicators, i = 1, . . . , n. Lin et al. (2013) further
extended the method for case 1 interval-censored data to case 2 interval-censored
data, under the PH model. The same as (3.1), a linear combination of I-splines is
used to provide an approximation of the baseline cumulative hazard function Λ0 (t).
In order to derive posteriors that are relatively easy to sample from, a two-step
data augmentation is employed. It was shown that the failure time of interest Ti is
equivalent to the time of the first occurrence of a recurrent event E for which the
number of occurrences N (t) within time interval (0, t] is a nonhomogeneous Poisson
process with mean value function Λ0 (t)exp(x′i β). Let two time points ti1 < ti2 such
that for left-censored observation, ti1 = Ri , for interval-censored observation, ti1 =
Li and ti2 = Ri , and for right-censored observation, ti2 = Li . Then two latent
variables Zi = N (ti1 ) and Wi = N (t2i ) − N (t1i ) are independent Poisson random
variables. Furthermore, mutually independent latent variables {Zil } and {Wil } are
derived similar to {Zil } in the previous section. Then the augmented data likelihood
is:
Laug =

"K
n
Y
Y

i=1 l=1

δi2 +δi3

Poi(Zil )Poi(Wil )

#

[I(Zi > 0)]δi1 [I(Zi = 0)]δi2 [I(Wi > 0)]δi2 [I(Zi = 0)]δi3 [I(Wi = 0)]δi3 .
The full conditional distributions of the latent variables {Zi }, {Zil }, {Wi }, {Wil },
and the coefficients {γl } are all of standard form. The full conditional distributions
of regression coefficients βr , r = 1, . . . , p, are not standard and are sampled using
ARMS. For more details, please refer to Lin et al. (2013).
3.2.3 Proportional Odds Model for Case 1 Interval-Censored Data Lin
and Wang (2011) developed an approach to analyze case 1 interval-censored data
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under the PO model:
F0 (t)
F (t|x)
=
exp(x′ β),
1 − F (t|x)
1 − F0 (t)

(3.2)

where ω(t) = F0 (t)/(1 − F0 (t)) is the baseline odds function. A linear combination
of I-splines is used to approximate ω(t) as in (3.1).
A data augmentation with Poisson latent variables was used to obtain posteriors
that are easy to sample from. Redefine left-censoring indicator as δi = I(Zi > 0);
′

latent variable Zi has conditional probability of Zi |ξi ∼ Poisson(ω(ci )exi β ξi ); and
ξi ∼ exp(1). Furthermore, based on the additive property of Poisson distribution
and the form of (3.1), import mutually independent latent variables Zil such that
Zi =

Pk

′

l=1

Zil and Zil ∼ Poisson(γl bl (ci )exi β ξi ). Then the data likelihood can be

expressed in terms of the latent variables as follows:
Laug =

" k
n
Y
Y

x′i β

Poi(Zil |γl bl (ci )e

#

ξi ) [I(Zi > 0)]δi [I(Zi = 0)]1−δi .

i=1 l=1

This is a product of Poisson probabilities, which makes most posterior distributions
to be of standard forms. In the Gibbs sampler, latent variables {Zi }, {Zil }, {ξi },
and spine coefficients {γl } are sampled from standard distributions, while regression
coefficients {βr } are sampled by ARMS algorithm.
3.2.4 Probit Model for General Interval-Censored Data The probit model
(Lin and Wang, 2009) specifies the cumulative distribution function (CDF) of failure
time T is modeled as: F (t|x) = Φ(α(t) + x′ β), where Φ is the CDF of the standard
normal distribution. A linear combination of I-splines is used to model α(t):
α(t) = γ0 +

K
X

γl bl (t),

l=1

where γ0 is an unconstrained constant, {γl } and {bl } are defined as before.
Let ti = Ri I(δi1 = 1) + Li I(δi1 = 0), a data augmentation with truncated normal
latent variable Zi is employed, where
zi ∼ N (α(ti ) + x′i β, 1),

with constraintzi ∈ Ai ,
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where Ai is interval (0, ∞) if δi1 = 1, (α(Li ) − α(Ri ), 0) if δi2 = 1, and (−∞, 0) if
δi3 = 1. The augmented likelihood now consists of constrained normal densities:
Laug =

n
Y

N (zi ; α(ti ) + x′i β, 1)

i=1

{I(zi > 0)}δi1 {α(Li ) − α(Ri ) < zi < 0}δi2 {I(zi < 0)}δi3 π(λi ).
The full conditional distributions for {Zi } are truncated normal. Coefficients γ0 ,
{γl } are sampled from standard distributions. The regression coefficients vector β is
sampled from a multivariate normal distribution.

3.3

ICBayes Package Design and Use

To use our package, infinity in right-censored observations should be written as NA.
There are four modeling methods included in the package: case2ph, case2probit,
case1po, and case1ph. case2ph and case2probit fit PH and probit model for general
interval-censored data respectively. case1po and case1ph fit PO and PH model for
case 1 interval-censored data only. A user can call these models through the model
argument using the main function ICBayes. The function ICBayes allows for a generic
input format where a user specifies the left endpoints L, right endpoints R, censoring
status, and covariate matrix, etc. Also it allows for a formula input format, where a
user inputs a survival object returned by the Surv function of the ‘survival’ package.
Most arguments in the ICBayes function are set to reasonable default values to
make it more convenient for users. For the I-splines, the order is set to be 2. The
default knots is set to be from minimum observed time point to maximum observed
time point, with length = 10. The Normal prior standard deviation for each β in the
PH model and case 1 PO model is set to be 10. The support of the target density for
sampling β using arms in library ‘HI’ is set to be (-5, 5) (coef_range = 5). The Normal
prior precision for the coefficient γ0 in the general interval-censored probit model is
set to be 0.1 (v0 = 0.1). The confidence level for CI of β is set to be 95% (conf.int
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= 0.95). The argument grids specifies a sequence of time points to estimate survival
probabilities for. Its default value is from minimum time point to maximum time
point, with length = 100. It is default that survival probabilities at grids are saved
in the output for plot (plot_S = TRUE). One may want to save the MCMC chains
for later convergence diagnosis. This can be done by setting chain.save = TRUE and
specifying a local .txt file to store the chains using argument dd1. Finally, the default
number of iterations is 5000, burn-in is 1000. One can let thin be a value greater than
1 to thin the MCMC chains. It is recommended that a user can adjust knots and
grids based on his/her data. It is also recommended that a user adjusts coef_range
based on his/her rough guess of the possible range for the regression coefficients β.
The available methods for the ICBayes object are print, $, and plot. The print
method prints as a list the estimated regression coefficients, sample standard deviation
of MCMC draws for each regression coefficient, and credible intervals. The $ method
allows picking out each component from the ICBayes object. The plot method plots
the estimated baseline survival function at the time points specified by grids. To use
the plot method, one must let the argument plot_S = TRUE. Then the estimated
baseline survival probabilities at grids are stored in the ICBayes function output,
though not printed by the print method.

3.4

Breast Cosmesis Example

To demonstrate the use of our package, we first analyze the general interval-censored
breast cancer cosmesis data from Finkelstein and Wolfe (1985). Early breast cancer
patients treated with either radiotheraph (x1 = 0) alone or radiotherapy with adjuvant chemotherapy (x1 = 1) were examined periodically for breast retraction. The
time unit is month. The following are the first few observations of the data.
> library(ICBayes)
> data(bcdata)
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> bcdata<-data.frame(bcdata)
> attach(bcdata)
> head(bcdata)
L

R status

x1

[1,] 45 NA

2

0

[2,]

6 10

1

0

[3,]

0

7

0

0

[4,] 46 NA

2

0

[5,] 46 NA

2

0

[6,]

1

0

7 16

3.4.1 Fit the PH Model for General Interval-Censored Data The following
function uses the formula input format and fits a PH model. The input data should
be data frame. The range of the observed time points (i.e., L and R) is from 0
to 60, so we set 10 equally spaced knots for I-splines using knots = seq(0.1, 60.1,
length=10), and we ask for survival estimation at grids = seq(0.1, 60.1, by=1). The
MCMC chain for β is stored in the file specified by dd1. The argument x_user =
c(0, 1) tells ICBayes to estimate survival at grids for x1 = 0 and for x1 = 1. For this
data, we only have one covaritae x1 . If we have more than one covariate, say, gender
and age, and we want to estimate the survival curve at gender = 0 and age = 50 and
another survival curve at gender = 1 and age = 50, then we should specify x_user =
c(0, 50, 1, 50).
> try1<-ICBayes(formula = Surv(L, R, type = "interval2") ~ x1,
+ data = bcdata, model = "case2ph", status = bcdata[, 3],
+ order=4, coef_range = 2, x_user=c(0,1), niter=11000,
+ knots=seq(0.1,60.1,length=10),grids=seq(0.1,60.1,by=1),
+ chain.save=TRUE, dd1 = ’C:/MCMC/bcdatapar.txt’)
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The result is as follows. Assume PH model is reasonable, we estimate the regression coefficient β to be 0.71, with a sample standard deviation of 0.27, and 95%
credible interval = (0.17, 1.25).
coef #Estimted regression coefficients
[1] 0.712153
coef_ssd #Sample standard deviation
[1] 0.2741571
coef_ci #Credible interval of coefficients
2.5 %CI 97.5 %CI
[1,] 0.1749649 1.251057
As shown in the code above, we have saved the MCMC chain for β in the local file
‘C:/MCMC/bcdatapar.txt’. Now we can perform convergence diagnosis. In Figure
3.1, a traceplot of the MCMC chain for β is created to check if it is mixed well and
stable. Our chain seems to converge.
> wd1<-paste(’C:/MCMC/’)
> setwd(wd1)
> f.name<-paste(’bcdatapar’,’.txt’, sep=’’)
> parest<-data.matrix(read.table(f.name))
> plot.ts(parest)
3.4.2 Fit the Probit Model for General Interval-Censored Data Since for
general interval-censored data, we have two types of models availabe in our package:
the PH model and the probit model, now, the probit model is fit to compare with
the PH model. In order to do that, one only needs to change model = “case2ph” to
model = “case2probit”.
> try6<-ICBayes(formula = Surv(L, R, type = "interval2") ~ x1,
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Figure 3.1 Traceplot of MCMC chain for β of case 2 PH model in breast cancer
study

+ data = bcdata, model = "case2probit", status = bcdata[, 3],
+ order=4, x_user=c(0,1), niter=11000,
+ knots=seq(0.1,60.1,length=10),grids=seq(0.1,60.1,by=1),
+ chain.save=TRUE, dd1 = ’C:/MCMC/bcdatapar2.txt’)
The result is as follows. Under the probit model assumption, the regression coefficient is estimated to be 0.48, with a sample standard deviation of 0.23, and a 95%
credible interval = (0.04, 0.93).
coef #Estimted regression coefficients
[1] 0.4818546
coef_ssd #Sample standard deviation
[1] 0.2254858
coef_ci #Credible interval of coefficients
2.5 %CI

97.5 %CI

[1,] 0.04456837 0.9277489

25

The traceplot of the MCMC chain of β in the probit model is presented in Figure
3.2. It shows that our chain mixes well and has converged to its stationary distribu-
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Figure 3.2 Traceplot of MCMC chain for β of case 2 probit model in breast cancer
study

3.4.3 Plot of Survival Functions for the Breast Cancer Data In the input
for both PH and probit models, we used c(0, 1) as the user-specified covariate vector,
which means estimating survival probabilities at grids for x1 = 0 and x1 = 1. Of
course, here S(t|x1 = 0) = S0 (t). Based on the survival probabilities stored in the
output, we can plot the estimated survival functions for the two treatment groups.
Using the code shown below, we plotted the estimated survival curves based on the
NPMLE method using the icfit function in the ‘interval’ package, and the case 2 PH
model and case 2 probit model in our package. In the ICBayes object, the vector that
stores the estimated survival probabilities at grids for x_user = c(0, 1) is S_m. Its
length is G∗2, where G = length(grids). The first G elements are the Ŝ(t|x1 = 0) and
the rest G elements are the Ŝ(t|x1 = 1) at grids. From Figure 3.3, we can see that our
two models produce similar results for the data. Compared to the step function based
on NPMLE (overlayed), our estimation is smooth since we connect point estimates
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with polynomials.
# compared to NPMLE plot
library(interval)
R2<-ifelse(is.na(R),Inf,R)
fit1<-icfit(Surv(L,R2,type = ’interval2’)~x1, data = bcdata)
plot(fit1)
S_m1<-matrix(try1$S_m,ncol=length(try1$grids),byrow=TRUE)
lines(try1$grids,S_m1[1,],col=2)
lines(try1$grids,S_m1[2,],col=2,lty=2)
S_m2<-matrix(try6$S_m,ncol=length(try6$grids),byrow=TRUE)
lines(try6$grids,S_m2[1,],col=3)
lines(try6$grids,S_m2[2,],col=3,lty=2)
rect(3,-0.035,20,0.2,col=’white’,border=NA)
legend(1,0.3,c(’x1=0 (NPMLE)’,’x1=1 (NPMLE)’,’x1=0 (case2PH)’,
’x1=1 (case2PH)’,’x1=0 (case2probit)’,’x1=1 (case2probit)’),
lty=c(1,2,1,2,1,2),col=c(1,1,2,2,3,3),cex=0.8)

3.5

Lung Cancer Example

Hoel and Walberg (1972) studied time to onset of lung cancer for two groups of mice:
one group living in conventional environment (96 mice, treatment = 1) and the other
group in germfree environment (48 mice, treatment = 0). Each mouse was sacrificed
at a random time to check for lung tumors. Hence it is case 1 interval-censored data.
The following are the first few observations from the data set. The time unit is day.
> library(ICBayes)
> data(lungdata)
> lungdata<-data.frame(lungdata)
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Figure 3.3 Estimated survival curves for two groups of patients in breast cancer
study

> head(lungdata)
L

R status treatment

1 0 381

1

1

2 0 477

1

1

3 0 485

1

1

4 0 515

1

1

5 0 539

1

1
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6 0 563

1

1

3.5.1 Fit the PH Model for Case 1 Interval-Censored Data Suppose we
want to fit a PH model, and for illustration purpose, this time we use the generic
input format. Now instead of putting L, R, and covariate matrix in a formula, we
specify them separately, and we do not have data argument. We observe that the
observed time points (i.e., L and R) range from 0 to 1008, ruthermroe, the observed
time points are not evenly distributed. So we set knots and grids as unequally spaced
to try to match with the data structure. Other arguments are the same.
> # generic form
> try2<-ICBayes(model="case1ph", L=lungdata[, 1],
+ R=lungdata[, 2], status=lungdata[, 3], xcov=lungdata[, 4],
+ niter=11000, x_user=c(0,1), order=2,
+ knots=c(0,100,200,300,400,seq(450,1008,length=50)),
+ grids=c(0,100,200,300,400,seq(402,1008,by=2)),
+ chain.save=TRUE,dd1 = "C:/MCMC/lungpar.txt")
The output is as follows. Assume the PH model is reasonable, we estimate the
regression coefficient β to be -1.11, with a sample standard deviation of 0.27, and
95% credible interval = (-1.66, -0.57). This is consistent with Huang (1996) which
concludes that mice in conventional environment seems to have lower risk of tumor
(p-value = 0.054).
coef #Estimted regression coefficients
[1] -1.113273
coef_ssd #Sample standard deviation
[1] 0.2749167
coef_ci #Credible interval of coefficients
2.5 %CI

97.5 %CI
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[1,] -1.659517 -0.5730999
We can look at the traceplot of the MCMC chain of β to check for convergence.
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Figure 3.4 Traceplot of MCMC chain for β in case 1 PH model for lung cancer data

3.5.2 Fit the PH Model for General Interval-Censored Data Since case 1
data is a special case of general interval-censored data, then we expect that our case
2 PH model should produce very similar results as the case 1 PH model. The results
will not be exactly the same, because our model construction processes are different.
For comparison, the case 2 PH model is fit using the code below:
# case2ph
> status_new=2*(lungdata[,3]==0)+0*(lungdata[,3]==1) # important!
> try7<-ICBayes(formula=Surv(L,R,type=’interval2’)~treatment,
+ data=lungdata,model=’case2ph’,status=status_new,
+ order=2,x_user=c(0,1),niter=11000,
+ knots=c(0,100,200,300,400,seq(450,1008,length=50)),
+ grids=c(0,100,200,300,400,seq(402,1008,by=2)),
+ chain.save=TRUE,dd1 = "C:/MCMC/lungpar2.txt")
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To be consistent with the methodology papers this package is based on, we have
used 1 to indicate left-censoring and 0 to indicate right-censoring for case 1 data.
We have used 0, 1, and 2 to indicate left-, interval-, and right-censoring for general
interval-censored data. So it is important to note that when we fit case 2 models for
case 1 data, our censorship variable need to be redefined using the first line of code
shown above.
We obtained the following result:
coef #Estimted regression coefficients
[1] -1.139954
coef_ssd #Sample standard deviation
[1] 0.2668109
coef_ci #Credible interval of coefficients
2.5 %CI

97.5 %CI

[1,] -1.675733 -0.6267516
The traceplot for our β suggests convergence, as seen in Figure 3.5. By comparing
with the results from fitting case 1 PH model, we can see that the point estimate,
the SSD, and the credible interval are all very close to their counterparts from for the
two models.
3.5.3 Plot of Survival Functions for the Lung Cancer Data In the input
for both case 1 and case 2 PH models, we used c(0, 1) as the user-specified covariate
vector, which means calculating survival probabilities at grids for treatment = 0
and treatment = 1. Of course, S(t|treatment = 0) = S0 (t). Based on the survival
probabilities stored in the ICBayes output element S_m, we can plot the estimated
survival functions for the two treatment groups, using the code shown below. From
Figure 3.6, we can see that the curves from case1PH and case2PH models are not
very close to that from the NPMLE. Actually, the NPMLE is based on Turnbull
intervals. The first Turnbull interval = (524, 546] for the treatment = 1 group. So
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Figure 3.5 Traceplot of the MCMC chain of β in case 2 PH model for lung cancer
data
the estimated survival probability before time = 524 days is 1. Similarly, the first
Turnbull interval = (371, 381] for the treatment = 0 group. So the corresponding
estimated survival probability befoer time = 371 is 1. However, our estimates are
smooth rather than step functions, so the estimated survival probabilities during the
two early periods are not going to be constantly 1.
# compared to NPMLE plot
library(interval)
L<-lungdata[,1]; R<-lungdata[,2]; treatment<-lungdata[,4]
R2<-ifelse(is.na(R),Inf,R)
fit1<-icfit(Surv(L,R2,type = ’interval2’)~treatment, data = lungdata)
plot(fit1)
S_m1<-matrix(try2$S_m,ncol=length(try2$grids),byrow=TRUE)
lines(try2$grids,S_m1[1,],col=2)
lines(try2$grids,S_m1[2,],col=2,lty=2)
S_m2<-matrix(try7$S_m,ncol=length(try7$grids),byrow=TRUE)
lines(try7$grids,S_m2[1,],col=3)
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lines(try7$grids,S_m2[2,],col=3,lty=2)
rect(400,-0.035,800,0.1,col=’white’,border=NA)
legend(0,0.4,c(’trt=0 (NPMLE)’,’trt=1 (NPMLE)’,
’trt=0 (case1PH)’,’trt=1 (case1PH)’,
’trt=0 (case2ph)’,’trt=1 (case2ph)’),
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Figure 3.6 Estimated survival curves for two groups of patients in lung cancer
study

33

Chapter 4
Modeling Interval-Censored Survival Data with
Spatial Correlation
In randomized clinical trials, subjects are recuited from different geographical regions.
Uncontrolled factors that vary spatially and exert an effect on study outcome may
cause dependency among subjects. Suppose a clinical trial for lung cancer is carried
out in China with patients being recruited from all the provinces. Then from this
mapping of air pollution particles in China (Figure 4.1) , we can see that particle level
varies greatly across the country, and two provinces closer to each other probably have
similar particle level. Since air quality may well affect a person’s lung function, it
suggests that patients may be spatially correlated. Patients from the same province
may be correlated because they share the same air quality, and a province’s air quality may be affected by its neighboring provinces. In this project, we will model the
described spatial dependency through the conditional autoregressive (CAR) distribution. Furthermore, suppose an endpoint of the trial is progression for lung cancer
patients, then the time-to-event is interval-censored, since progression can only be
examined by CT scan very few weeks.
The conditional autoregressive (CAR) distribution is the most commonly used
model for region-specific random effects. Different from commonly used random effects that are assumed to be independently and identially distributed, the spatial
random effects are dependent and they jointly follow the CAR distribution. Hodges
et al. (2003) derived the correct power for the precision parameter in the CAR model.
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Figure 4.1 A recent mapping of air pollution particle levels in China
Banerjee et al. (2003) modeled spatially correlated frailties using both geostatistical approach and lattice approach under Weibull PH model. Banerjee and Carlin
(2004) modeled spatially correlated time-to-relapse in a Minnesota smoking clinical
trial through parametric cure rate models with multivariate conditional autoregressive
(MCAR) prior for spatial random effects. Jin et al. (2005) further extended MCAR
model for lattice data to generalized MCAR where they demonstrated its use under
Gaussian model and Poisson model. Not so much work has been done for spatially
correlated data, and most of them has been conducted under parametric settings,
such as normal, Poisson, or Weibull PH models. Because real-life survival data are
usually complicated, parametric models are typically not flexible enough to provide a
good fit for the true survivorship. In this project, we introduce an efficient and easyto-implement Bayesian approach for analyzing general interval-censored data with
spatial correlation under semiparametric PH model.
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4.1

Proportional Hazards Model with Spatial Random Effect

4.1.1 Data and Likelihood Function Suppose there are I areas and the ith area
contains ni subjects. Let Tij denote the failure time for the jth person in the ith
area and (Lij , Rij ] the observed interval for Tij , where i = 1, . . . , I and j = 1, . . . , ni .
Let xij denote the p × 1 covariate vector for person j in area i. Let φi denote the
spatial random effect for area i. We consider a mixed PH model for Tij , for which
the survival function of Tij given xij and φi is
n

o

S(t|xij , φi ) = exp −Λ0 (t)exp(x′ij β + φi ) ,
where Λ0 (t) is the baseline cumulative hazards function. Furthermore, let δ1ij , δ2ij , δ3ij
be the left-, interval-, and right-censoring indicators for person j in area i. Let (β, Λ0 )
denote the unknown parameters in the model, then the observed data likelihood is:
Lkobs (Λ0 , β) =

I Z
Y



Lki (Λ0 , β|φi )π(φi )dφi ,

i=1

where Lki (Λ0 , β|φi ) =

Qni

j=1

(4.1)

Lkij (Λ0 , β|φi ) is the conditional likelihood contributed

by the subjects in the ith area given the random effect φi , and:
Lij (Λ0 , β|φi ) =

(4.2)

{F (Rij |xij , φi )}δij1 {F (Rij |xij , φi ) − F (Lij |xij , φi )}δij2 {1 − F (Lij |xij , φi )}δij3 .
Using the observed likelihood for Bayesian computation is difficult because the
integral in the observed likelihood (4.1) does not have an explicit form. To overcome
this, we consider the following form of likelihood function treating all φi ’s as unknow
parameters:
Lk(Λ0 , β, φ) =

I
Y

{Lki (β, Λ0 )π(φi )} .

i=1

4.1.2 Estimating Λ0 (t) The above model is semiparametric as Λ0 (t) is a totally
unspecified non-decreasing function. Estimating Λ0 (t) is challenging since it is infinite
dimensional. For right-censored data, there exists a partial likelihood that allows us
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to estimate the regression parameters β directly without the need of estimating Λ0 (t)
under the PH model (Cox, 1972). However, the partial likelihood does not exist
for interval-censored data (Sun, 2006), and we need to estimate both β and Λ0 (t)
simultaneously. Following Joly et al. (1998) and Cai et al. (2011), we model Λ0 (t)
with a linear combination of monotone splines (Ramsay, 1988):
Λ0 (t) =

K
X

γl bl (t),

(4.3)

l=1

where {bl } is a set of basis splines (I-splines), each of which is nondecreasing from
0 to 1, and {γl } is a set of non-negative coefficients. To construct the set of basis
splines, we need to specify the order for them and an increasing sequence of knots
within the data range. The basis splines are fully determined once knots and order
are specified. The number of basis splines equals the number of interior knots plus
the order. The order taking values of 1, 2, and 3 produces linear, quadratic, and cubic
basis splines respectively. We recommend to take 2 or 3 as order value for adequate
smoothness and to take 10-30 equally spaced knots for adequate modeling flexibility
from our intensive experiences (Lin and Wang, 2010; Wang and Dunson, 2011; Cai
et al., 2011).
4.1.3 Data augmentation Although one may use Metropolis-Hastings algorithms to sample all the parameters, it is difficult to find good proposal distributions
to obtain reasonable acceptance rates and well mixed MCMC chains. In the following, we propose a two-step data augmentation to facilitate posterior computation by
taking advantage of the PH model structure and the spline modeling form of Λ0 (t).
Assume that there is an underlying recurrent event E, for which the number of occurrences N (t) within time interval (0, t] is a nonhomogeneous Poisson process with
mean function Λ0 (t)exp(x′ β + φ). Define T as the the time of the first occurrence
of E. This latent process totally determines T , since P (T > t) = P (N (t) = 0) =
exp {−Λ0 (t)exp(x′ β + φ)} is our survival function.
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Let time points t1 < t2 . Specifically, for left-censoring, t1 = R; for intervalcensoring, t1 = L and t2 = R; and for right-censoring, t2 = L, where (L, R] is
the observed interval for T . By the properties of nonhomogeneous Poisson process, random variable Z = N (t1 ) ∼ Poi(Λ0 (t1 )exp(x′ β + φ)), random variable W =
{N (t2 ) − N (t1 )} ∼ Poi({Λ0 (t2 ) − Λ0 (t1 )} exp(x′ β + φ)), and Z and W are independent conditional on φ. For left-censored data, W is not defined. The reason
is that t2 is some point greater than t1 = R, so W can take any integer value
and will not contribute any information about the failure time T . For intervalcensored data, Z = 0 and W > 0. For right-censored data, t1 is some point that
is less than t2 = L, so Z = W = 0. According to our data structure, for the
jth subject in the ith area, we define tij1 and tij2 analogous to t1 and t2 , and
Zij and Wij analogous to Z and W . Then Zij ∼ Poi(Λ0 (tij1 )exp(x′ij β + φi )) and
Wij ∼ Poi({Λ0 (tij2 ) − Λ0 (tij1 )} exp(x′ij β + φi )). The augmented data likelihood for
subject j in area i is:
Lkaug1ij (θ|Zij , Wij , φi ) =
Poi(Zij )Poi(Wij )δij2 +δij3 [Zij > 0]δij1 [Zij = 0]δij2 [Wij > 0]δij2 [Zij = 0]δij3 [Wij = 0]δij3 .
Integrating out Zij and Wij will lead to the conditional likelihood Lkij (θ|φi ) in (4.2).
Furthermore, based on the additive property of Poisson distribution and the spline
modeling form of Λ0 (t) in (4.3), we decompose Zij and Wij as follows: Zij =
and Wij =

PK

l=1

PK

l=1

Zijl

Wijl , where Zijl ’s and Wijl ’s are mutually independent, Zijl ∼

Poi(γl bl (tij1 )exp(x′ij β + φi )), Wijl ∼ Poi({γl bl (tij2 ) − γl bl (tij1 )} exp(x′ij β + φi )), with
constraints
and

PK

l=1

PK

l=1

Zijl > 0 if δij1 = 1,

Zijl = 0 and

PK

l=1

PK

l=1

Zijl = 0 and

PK

l=1

Wijl = 0 if δij3 = 1. Then for subject j in area i, the

augmented data likelihood based on Zijl ’s and Wijl ’s is:
′
′
Lkaug2ij (θ|Zijl
s, Wijl
s, φi )

=

Wijl > 0 if δij2 = 1 ,

(K
Y

δij2 +δij3

Poi(Zijl )Poi(Wijl )

l=1

)

[Zij > 0]δij1 [Zij = 0]δij2 [Wij > 0]δij2 [Zij = 0]δij3 [Wij = 0]δij3 .
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This likelihood function is simply a product of Poisson probability mass functions,
which will lead to a straightforward posterior computation to be presented later.
4.1.4 Spatial Random Effects A common model for lattice data is conditional
autoregressive (CAR) distribution, originally developed by Besag (1974). Let φ =
(φ1 , . . . , φI ) be the spatial random effect vector, then the general form of CAR model
is (Besag and Kooperberg, 1995),
(I−B)/2
τφ
exp

p(φ) ∝





τφ
− φ′ Qφ ,
2

(4.4)

where Q is an I × I positive definite symmetric matrix. B is the number of disconnected groups of areas (Hodges et al., 2003). For the South Carolina map and
Minnesota map used in our study, there is only one group of areas respectively, so
B = 1. While if there is one or more islands that are disconnected from other areas,
then B is greater than 1. For example, in the Scottish lip cancer study (Clayton
and Kaldor, 1987), there are three islands (Orkneys, Shetland, and Outer Hebrides
islands) in addition to the mainland of Scotland, so the total number of disconnected
groups of areas is B = 4.
By Brook expansion (Brook, 1964), (4.4) is also equivalent to:
X

φi |φ−i ∼ N(

ζij φj , κi ),

for i = 1, . . . , I,

(4.5)

j

with ζii = 0, ζij = −(Qij /Qii ) for i 6= j, and κi = 1/Qii . i ∼ j denotes that areas
i and j are neighbors, and φ−i is the set of all spatial random effects except for the
one for area i.
If we specify Q in a way such that Q1 = 0, then we get the so called intrinsic
conditional autoregressive (ICAR) model (Besag and Kooperberg, 1995). Now equations (4.4) and (4.5) still hold, however, Q is positive semi-definite and the variance
matrix Q−1 no longer exists. An algebraic decomposition of the power term in (4.4)
leads us to
(I−B)/2

p(φ) ∝ τφ


1 X

exp 

2

i<j

39




Qij (φi − φj )2  .

(4.6)

Note that now φi ’s are actually non-identifiable, as we can add any same value to
all φi ’s, and (4.6) still remains the same. In Bayesian implementation, we impose
an identifying sum-to-zero constraint by centering the φi ’s around zero after each
iteration (Carlin and Louis, 2000, p.263).
Spatial statistics practice usually furthermore specifies ζij =

1
1
,
mi (i∼j)

and κi =

1/(mi τφ ), where mi is the number of neighbors for area i, and τφ is a precision
parameter. Then Q = τφ W , where Wii = mi and Wij = −1(i∼j) . Now (4.6) becomes
p(φ) ∝




τφ
(I−B)/2
τφ
exp −
2

X
i<j




(φi − φj )2 1(i∼j)  ,

(4.7)

for i = 1, . . . , I,

(4.8)

Again by Brook expansion, (4.7) is equivalent to
φi |φ−i ∼ N(φ∂i , 1/(mi τφ )),

where φ∂i is area i’s neighbor mean of random effects. This conditional distribution
(4.8) is to be used as prior for φi in our MCMC sampling algorithm.
4.2

Prior specifications and posterior computation

For coefficients γl , l = 1, . . . , K, we choose an exponential prior, γl ∼ exp(η), and
a hyperprior for η, η ∼ Ga(aη , bη ). This specification leads to conjugate posteriors
for both γl ’s and η. For spatial precision parameter τφ , we choose a gamma prior,
τφ ∼ Ga(aτ , bτ ), which also leads to a conjugate posterior. For regression coefficients
βr , r = 1, . . . , p, we assume a normal prior βr ∼ N(0, σ02 ). The posterior full consitional for βr is not conjugate, and we use the adaptive rejection Metropolis sampling
(ARMS) algorithm (Gilks et al., 1995) for sampling. The posterior for each φi is not
conjugate either. We use the Metropolis-Hastings algorithm for sampling.
After initializing values for the parameters, the proposed MCMC algorithm iterates through the following steps.
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• Set Zij = 0 and Wij = 0 for all i and j, Zijl = 0 and Wijl = 0 for all i, j, and l.
If δij1 = 1, then sample
Zij ∼ Poi(Λ0 (Rij )exp(x′ij β + φi ))1(Zij >0) ,
(Zij1 , . . . , ZijK ) ∼ Multinomial(Zij , pij ),

pij ∝ (γ1 b1 (Rij ), . . . , γK bK (Rij )).

If δij2 = 1, then sample
Wij ∼ Poi({Λ0 (Rij ) − Λ0 (Lij )} exp(x′ij β + φi ))1(Wij >0) ,
(Wij1 , . . . , WijK ) ∼ Multinomial(Wij , qij ),
qij ∝ (γ1 {b1 (Rij ) − b1 (Lij )} , . . . , γK {bK (Rij ) − bK (Lij )}).
• Sample βr , r = 1, . . . , p, using ARMS method from its full conditional distribution
p(βr |Zij′ s, Wij′ s, Λ0 , β−r , φ) ∝
ni
I X
X

exp(

(x′ij β)(Zij δij1 + Wij δij2 )

i=1 j=1

−

ni
I X
X

′

exij β+φi {Λ0 (Rij )(δij1 + δij2 ) + Λ0 (Lij )δij3 })p(βr ),

i=1 j=1

where p(βr ) = N (0, σ02 ) is the prior used for βr , and β−r denotes all the β’s
except for βr .
• Sample γl , l = 1, . . . , K, from Ga(aγl , bγl ), where
aγl = 1 +

ni
I X
X

(Zijl δij1 + Wijl δij2 ),

i=1 j=1

bγl = η +

ni
I X
X

′

exij β+φi {bl (Rij )(δij1 + δij2 ) + bl (Lij )δij3 } .

i=1 j=1

• Sample η from Ga(aη + K, bη +

PK

l=1

γl ).

41

• Sample φi , i = 1, . . . , I, using MH from its full conditional distribution
p(φi |Zij′ s, Wij′ s, Λ0 , β, φ−i ) ∝
exp(

ni
X

φi (Zij δij1 + Wij δij2 ) −

ni
X

′

exij β+φi {Λ0 (Rij )(δij1 + δij2 ) + Λ0 (Lij )δij3 })

j=1

j=1

p(φi |φ−i ),
where p(φi |φ−i ) denotes the prior in (4.8).
• Based on prior (4.7), sample τφ from Ga( I−1
+ aτ , b τ +
2
4.3

1
2

P

i<j (φi

− φj )2 1(i∼j) ).

Model Comparison

To evaluate the performance of our proposed model, we compared it to a Weibull
proportional hazards model with spatial random effects. The later can be easily
fitted in WinBUGS, which also allows the use of the CAR distribution as prior for the
spatial random effect vector. We consider the following two Bayesian model selection
criteria: the deviance information criterion (DIC) (Spiegelhalter et al., 2002) and
pseudo-marginal likelihood (PsML) (Geisser and Eddy, 1979; Gelfand et al., 1992).
DIC is derived for the purpose of comparing complex hierarchical models. It is a
Bayesian analogue of AIC, and can be readily computed in Markov chain Monte Carlo
analysis. Let ω be the set of all parameters in the model of interest, the Bayesian
deviance is defined as
D(ω) = −2logf (y|ω) + 2logh(y),

(4.9)

where f (y|ω) is the likelihood for the observed data y and h(y) is some standardizing
function of data alone. Since the second term in (4.9) is free of ω, then for our
comparison, it can be ignored in deviance calculation given that we are comparing
models based on the same data set. Based on Bayesian deviance, a measure for the
effective number of parameters in a model is defined as
pD = D − D(ω),
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where D = E(D|y) is the posterior mean of deviance, and D(ω) = D(E(ω|y)) is the
deviance at posterior means of parameters. DIC is defined as the sum of D and pD
in parallel of the definition of AIC and BIC, where D measures the model fit. Similar
to AIC and BIC, a smaller value of DIC indicates a better model.
We also compared the two models with the PsML based on conditional predictive ordinate (CPO). For each observation i, CPO is defined as the cross-validation
posterior predictive density conditional on the rest of the observations (Dey, et al.,
1997):
CPOi = f (yi |y−i ) =

Z

f (yi |ω, y−i )f (ω|y−i ))dω,

where y−i denotes all the observations but observation i. A Monte Carlo estimate of
CPOi is given by

"

T 

1X
CPOi =
1/f (yi |ω (t) )
T t=1

#−1

where f (yi |ω (t) ) is the ith individual likelihood evaluated at iteration t. The product
of CPOs,

Qn

i=1

f (yi |y−i ), called psdudo-marginal likelihood (PsML), has been pro-

posed to be a surrogate for f (y) by Geisser and Eddy (1979). The negative natural
log of PsML is called negative cross-validatory log likelihood (NLLK) and is used for
model comparison (Cooper et al., 2003). A smaller value of NLLK implies a better
model. Note that for comparing two models M 1 and M 2,
Qn

f (yi |y−i , M1 )
),
i=1 f (yi |y−i , M2 )

where the term

NLLK1 − NLLK2 = −log( Qi=1
n
Qn

f (yi |y−i , M1 )
i=1 f (yi |y−i , M2 )
i=1

Qn

is the pseudo-Bayes factor (Geisser and Eddy, 1979; Gelfand and Dey, 1994). An
advantage of the pseudo-Bayes factor and the NLLK is that they can be used with
improper priors.
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4.4

A Simulation Study

We evaluated the performance of our model through a simulation study. A total of
100 data sets were generated. For each data set, the spatial layout is based on the
46 counties in South Carolina, with 10 subjects in each county. For each data set,
failure times were generated from the mixed PH model:
S(t|xij1 , xij2 ) = exp {−Λ0 (t)exp(β1 xij1 + β2 xij2 + φi )} ,

(4.10)

where Λ0 (t) = log(1 + t), β1 = 1, β2 = 1, τφ = 4, xij1 ’s ∼ Bernoulli(0.5), and xij2 ’s
∼ N(0, 0.52 ). We assume that the random number of medical examinations performed
for each person is 1 plus a Poisson random number with mean 2. The gap times
between adjacent medical examinations follow an exponential distribution with mean
1. The observed interval is formed by the consecutive examination times (including
0 and ∞) that contains the true failure time. To generate spatial random effect
φi ’s, we first generated φi *’s from multivariate normal NI (0, (τφ W ∗ )−1 ), where W ∗ =
W + diag(0.0001, I), and then centered φi *’s around zero to get φi ’s. We imported
W ∗ to make the precision matrix invertible, and put the sum to zero constraint to
make the φi ’s identifiable.
To construct the monotone splines, we set the order of I-splines as 2 and chose 15
equally spaced knots within the range of observed times. For hyper-parameters, we
set σ02 = 100, aη = 1, and bη = 1. For the spatial precision parameter τφ , we select
aτ = 8 and bτ = 2 to give a priror with over 99% densities between 0 and 10. We
also fitted the same 100 data sets using a spatial Weibull PH model in WinBUGS.
For each MCMC sampling of both our model and the Weibull model, we drew 11,000
iterations and discard the first 1,000 as a burn-in. We compared the two models based
on frequentist operating characteristics of estimated coefficients, model goodness of
fit, and estimation of the baseline survival function S0 (t).
From the theory of Markov chains, we would expect our chains to converge to
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their stationary distributions. Although we can never be sure of convergence, there
are several tests available in the ’coda’ package in R to see if the chains appear to
be converged. Here we show the traceplots (Figure 4.2, Figure 4.3, and Figure 4.4)
and Gewke’s diagnostic (Geweke, 1992) for regression coefficients β1 , β2 , and spatial
precision parameter τφ , from the first simulated dataset. Basically, the Geweke’s
diagnostic produces a Z-score for a test of equality of means between the first and last
parts of the chain. Based on the Z-score, a corresponding p-value can be calculated.
Table 4.1 presents the z-scores and p-values for the Geweke’s tests. All the p-values
are greater than 0.05. Based on both graphic and non-graphic diagnostics, it seems
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Figure 4.2 Traceplot of fixed effect β1 in the 1st simulated dataset.

Table 4.2 summarizes the estimation results of our model versus the Weibull
model. For each parameter, the point estimate is the average of the 100 posterior
means, the empirical standard error (ESE) is the average of the 100 estimated standard errors, the sample standard deviation (SSD) is the sample standard deviation
of the 100 posterior means, and the 95% coverage probability (95CP) is the percent
of the 100 credible intervals for each βr that contains the true parameter value. We
can see that the proposed model works very well. The percent bias is only 4.7% for
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Figure 4.3 Traceplot of fixed effect β2 in the 1st simulated dataset.
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Figure 4.4 Traceplot of spatial precision τφ in the 1st simulated dataset.
β1 and 1.4% for β2 . The coverage probabilities are close to the nominal level of 0.95.
Both models provide similar precision in estimation. In contrast, the point estimates
from the Weibull model are very biased, as the percent bias is 32.6% for β1 and 32.0%
for β2 . The magnitudes of DIC and NLLK under the Weibull model are much larger
than those under the proposed model, indicating a decisive evidence of favoring the
proposed model (Kass and Raftery, 1995).
We estimated S0 (t) at 100 equally spaced points {g1 , . . . , g100 } within the data
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Table 4.1 Geweke’s convergence diagnostic for MCMC chains of the model
parameters in the 1st simulated dataset
Paramter Z-score p-value

β1

-1.5372

0.1242

β2

-0.5737

0.5662

τφ

0.7077

0.4791

Table 4.2 Estimation results for simulation 1
Proposed Model

Weibull Model

True

Estimate

SSD

ESE

95CP

Estimate

SSD

ESE

95CP

β1

1

1.047

0.156

0.141

0.93

0.674

0.133

0.112

0.21

β2

1

1.014

0.121

0.133

0.97

0.680

0.117

0.113

0.19

τφ

4

3.954

0.547

1.247

1.00

4.431

0.507

1.323

1.00

DIC

726

1149

NLLK

364

520

range using the proposed model and the Weibull model. The estimated baseline
survival functions and the true baseline survival function are plotted in Figure 4.5. For
the proposed model, the 95% credible interval for each S0 (gd ) averaged over the 100
data sets are also plotted (dotted lines), where d = 1, . . . , 100. The estimated S0 (t)
curve from our model provides a very good approximation to the true S0 (t) curve.
Also our 95% pointwise credible intervals totally cover the true baseline survival
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curve. On the other hand, the estimated S0 (t) curve from the Weibull model only
provides a reasonably good estimation between time unit 0 and 1, then it diverges
from the true curve very fast. This graph demonstrates that parametric assumption of
baseline survival time can be too rigid. On the contrary, the proposed semi-parametric
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Figure 4.5 Plot of estimated baseline survival curve based on 100 simulated data
sets using proposed model (with 95% pointwise credible intervals) and Weibull
model, compared to true baseline survival curve (simulation 1).

To investigate the spatial pattern of survivorship, we plotted the posterior means
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of the spatial random effects (φi ’s) based on both the proposed model and the Weibull
model for a randomly selected simulated data set (Figure 4.6). Note that each frailty
corresponds to a county in South Carolina in the map. The two maps in Figure 4.6
use the same grayscale. Both maps show higher values of φi in the middle part of the
state.
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[0.2,0.4)
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Figure 4.6 Maps of posterior means for the spatial random effects φi over 46 counties of
SC based on proposed model and Weibull model (simulation 1).

To give the Weibull PH model with spatial random effect in WinBUGS an advantage so as to further test our proposed model, we performed a second simulation
by generating data based on a Weibull PH model with spatal random effect. We let
λ0 (t) = rtr−1 , r = 1.5 in model (4.10). Other parameters are the same as in the
first data model. We fit both our model and the spatial Weibull PH model in WinBUGS, with r ∼ Ga(1, 1) as prior for r, and other priors and hyperparameters are
the same as in the first simulation setting. The convergence of the MCMC chains are
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checked with traceplots and Geweke’s diagnostic (not shown). The estimation results
are summarized in Table (4.3). As we expected, the estimates from the Weibull PH
model with spatial random effect are very close to the true values, since the simulated
data are generated from it. For this different failure time distribution, our model still
gives accurate estimation for the regression coefficients and the spatial precision. The
coverage probabilities for β1 and β2 are close to the nominal 95% level. This implies
the robustness of our method to different underlying distributions for T . The DIC
and NLLK values from the two models are very close, which furthermore shows our
model is as good as the Weibull model for this parametric setting.
Table 4.3 Estimation results for simulation 2
Proposed Model

Weibull Model

True

Estimate

SSD

ESE

95CP

Estimate

SSD

ESE

95CP

β1

1

0.993

0.187

0.158

0.92

1.001

0.210

0.155

0.90

β2

1

1.006

0.155

0.154

0.95

1.015

0.150

0.154

0.94

τφ

4

4.057

0.514

1.297

1.00

4.085

0.506

1.299

1.00

r

1.5

1.505

0.123

0.106

0.96

DIC

525

527

NLLK

263

264

The baseline survvial S0 (t) at 100 equally spaced points {g1 , . . . , g100 } within the
data range are also estimated using our model and the Weibull model. Figure 4.7 is
the plot of the estimated survival functions and the true function, with 95% pointwise
credible intervals from our model for each S0 (gd ), d = 1, . . . , 100. The estimated
S0 (t) curves from our model and the Weibull model almost match exactly with the
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true S0 (t) curve. And the pointwise credible intervals totally cover the true baseline
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Figure 4.7 Plot of estimated baseline survival curve based on 100 simulated data
sets using proposed model (with 95% pointwise credible intervals) and Weibull
model, compared to true baseline survival curve (simulation 2).

4.5

Smoking-Relapse Data Application

We now apply our proposed model to a geographically referenced smoking-relapse
data set consisting of 223 subjects living in 51 zip code areas in the southeastern corner
of Minnesota. This data is a subset from a lung health study carried out by Murray
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et al. (1998) on the effect of intermittent smoking on pulmonary function. The 223
smokers selected all have quit smoking at least once during the study period and
have a Minnesota zip code of residence. The event of interest is relapse to smoking.
Each zip code area forms a spatial cluster. Subjects were monitored at annual visits
for 5 years. The time origin for each subject is the study entry time. There are
four prognostic factors of interest: gender, duration as a smoker (years), treatment
(smoking intervention (SI), usual care (UC)), and average number of cigarettes per
day over the last 10 years. Each subject has two time points referring to the observed
interval where true time to relapse falls in, so it is an interval-censored data set. One
thing to point out is that there is actually no left-censoring in this particular data
set. However, our method is certainly applicable for data sets that contain all three
types of censorship.
For the analysis, our goal is to estimate the effect of the four prognostic factors
on time to relapse to smoking, after adjusting for the spatial dependency within and
among clusters. We analyzed the data using both our proposed model and the spatial
Weibull PH model in WinBUGs. For the MCMC chains of regression parameters β1
through β4 , we looked at traceplots (Figure 4.8 to Figure 4.11) and the Geweke’s
diagnostic (Table 4.4) to examine convergence. The traceplots show that all of the
MCMC chains mix very well and are very stable. Also, all of the p-values for Geweke’s
diagnostic are greater than 0.05, indicating convergence for the MCMC chains.
The regression estimation results are presented in Table 4.5. The estimated regression coefficients from both models have same direction and similar magnitude.
However, smoking intervention is significantly effective in reducing relapse risk based
on our model, while the Weibull model fails to detect this significance. Duration
of smoking is also significant based on our model, although the magnitude is small.
Duration as a smoker may be confounded with age, and younger people may tend
to relapse more often. The DIC and NLLK values are lower for the proposed model
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Figure 4.8 Traceplot of fixed effect β1 in the smoking-relapse data.
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Figure 4.9 Traceplot of fixed effect β2 in the smoking-relapse data.
than for the Weibull model, which implies that our model has a better fit for the
data.
We also checked the performance of the proposed model from the perspective
of survivorship estimation. In Figure 4.12, we plotted the nonparametric maximum
likelihood estimates using the Turnbull method (Turnbull, 1976; Giolo, 2004), the
proposed estimates, and the Weibull estimates of the survival functions for the four
gender and treatment interaction groups. Turnbull (1976) proposed a nonparametric
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Figure 4.10 Traceplot of spatial precision τφ in the smoking-relapse data.
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Figure 4.11 Traceplot of spatial precision τφ in the smoking-relapse data.
maximum likelihood estimator of survival function for interval-censored data. The
estimated curves from the proposed model are close to the Turnbull curves, indicating
that our model fit the data well. In contrast, the Weibull model seems to constantly
underestimate the true survival probabilities, and the magnitude of divergence from
the other two methods increases quickly after around 1.5 years.
From the plot of Turnbull estimates, males with smoking intervention has the
highest survivorship, and the rest three groups are roughly similar to each other.
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Table 4.4 Geweke’s convergence diagnostic for MCMC chains of the model
parameters in the smoke-relapse data
Paramter Z-score p-value

β1

-1.4203

0.1556

β2

-1.4716

0.1411

β3

-1.2607

0.2074

β4

-0.8535

0.3934

From the curves based on the proposed model and the Weibull model, the survival
probability is the highest for males with smoking intervention, followed by females
with smoking intervention, males with usual care, and finally females with usual
care. Figure 4.12 suggests that smoking intervention is effective in reducing the risk
of relapse, and women may be more likely to relapse than men. This agrees with the
regression estimates in Table 4.5.
To explore the spatial pattern, in Figure 4.13, we mapped the posterior means
of spatial frailties (φi ’s) for the smoking data, using the proposed model and the
Weibull model. Note that a same grayscale is used for both maps. There are 83
zip code areas in total, with only 51 of them containing data. The 32 zip code areas
without data are plotted in white color. The map based on the proposed model shows
higher values for φi ’s in the northwest region, which indicates higher risks of relapse
in this region. This pattern also agrees with the finding from Banerjee and Carlin
(2004), where they fitted a spatial MCAR Weibull cure rate model. The map based
on the Weibull model also show somewhat higher values for φi in the same region,
but in a less accentuated way.
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Table 4.5 Estimation results for the smoking cessation study
Proposed Model

Weibull Model

Estimate

95%CI

Estimate

95%CI

Gender (male=0)

0.255

(-0.246,0.747)

0.374

(-0.122, 0.870)

Duration as a smoker

-0.056

(-0.084, -0.029)

-0.030

(-0.065, 0.004)

Treatment(UC=0)

-0.555

(-1.065, -0.025)

-0.405

(-0.929, 0.153)

Cigarettes per day

0.001

(-0.020, 0.022)

0.009

(-0.013, 0.030)

r

—

—

2.218

(1.652, 2.782)

DIC

399

456

NLLK

200

224
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Figure 4.12 Estimated survival curves for the smoking cessation study, using
Turnbull method, proposed model, and Weibull model; event of interest is time to
relapse to smoking. Four curves are plotted for each method based on the four
subgroups formed by gender and treatment.
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Figure 4.13 Maps of posterior means for the spatial random effects φi over 51 zip codes
areas in southeast Minnesota based on proposed model and Weibull model. The other 32
zip code areas without data are plotted in white color.
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Chapter 5
Multivariate Frailty Model for Clustered
Interval-Censored Data
5.1

Introduction

In medical studies, time-to-event of interest may not be directly observed but is
known to fall within a certain interval. Such data are referred to as interval-censored
(Finkelstein and Wolfe, 1986) and they occur naturally in infectious disease studies or
oncology clinical trials where patients are periodically checked by lab examinations
for infection or cancer progression. Furthermore, event times in a cluster may be
correlated. For example, in multi-center clinical trials, patients and clinical practice
characteristics that vary by center may exert an influence on treatment outcome. If
these effects are sufficiently powerful, then inferences that ignore the clustering can
be misleading.
The concept of frailty, first introduced by Vaupel et al. (1979), is widely used
in survival analysis to characterize the heterogeneity among clusters. Goethals et
al. (2009) modeled interval-censored clustered cow udder quarter infection times
by proportional hazards (PH) model with a gamma frailty. Zhang and Sun (2010)
proposed a multiplier for survival function based on cluster size or a within-cluster
resampling procedure to avoid the correlation issue with clusters. Kim (2010) modeled
failure times and cluster size jointly using PH model with normal random effect and a
mixed ordinal regression model. Those methods have focused on one shared frailty or
equivalently one random intercept term to account for variation in baseline risk across
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clusters. A natural extension is to also allow for variation of treatment effect across
clusters. This has been done for right-censored failure times (Ripatti and Palmgren,
2000; Vaida and Xu, 2000). Furthermore, instead of directly presuming a random
effect term, one may first want to test its existence.
To address the problem of identifying random effects in survival analysis, Dunson
and Chen (2004) developed a multivariate frailty model for right-censored event times.
Defining a PH model with both random intercept and random effect for binary predictors, they assigned priors for the frailty variances that are mixtures of point mass
at zero and inverse-Gamma densities. Cai (2010) extended Dunson and Chen (2004)
method to allow for nonparametric modeling for log of the multivariate frailties. Here
we modified the Dunson and Chen (2004) approach to the problem of selecting random
effects in interval-censoring setting when there is a subset of predictors with possibly
heterogeneous coefficients. In addition, we model the cumulative hazard function
nonparametrically. A Markov chain Monte Carlo (MCMC) algorithm is developed to
estimate the probability that a frailty exists and to obtain the Bayes Factor for testing. The inferences on population parameters are model-averaged in the sense that
we have accounted for the uncertainty in the frailty selection. Although we follow the
frailty selection procesure in Dunson and Chen (2004), the specific interval-censoring
data structure necessitates a fundamentally different model construction process.

5.2

Prior and Augumentation for Frailties

Consider the following multivariate frailty proportional hazards model:
(

λij (t|xij ) = λ0 (t) ξi1

H
Y

xijh
ξi,h+1

h=1

)

exp(x′ij β)

(5.1)

where there are i = 1, . . . , I clusters, and j = 1, . . . , ni subjects within each cluster
i. The xijh , h = 1, . . . , H, indicate binary predictors, ξi1 is the baseline frailty, ξi2 to
ξi,H+1 are the frailties related to xij1 to xijH .

60

For each frailty ξih , h = 1, . . . , H + 1, we specify its prior as



 1(ξih = 1),

π(ξih ; κh ) = 

if κh = 0

−1

 Ga(ξih ; κ−1
h , κh ),

if κh > 0

where the Gamma density has mean 1 and variance κh . The mean of 1 makes the average hazard identifiable. And the variance κh measures the degree of between-cluster
variability and thus the level of within-cluster dependence (Glidden and Vittinghoff,
2004). As we know, if κh = 0, then ξih ≡ 1 for all i. This corresponds to the null
hypothesis of homogeneity, or equivalently, zero within-cluster correlation. We choose
the following mixed prior for κh :
π(κh ) = 1(κh = 0)π0h + 1(κh > 0)(1 − π0h )IG(κh ; ah , bh ),

(5.2)

where π0h = Pr(H0 : κh = 0) is the prior probability of the null hypothesis of
homogeneity for the hth frailty, and IG(·; ah , bh ) is the inverse Gamma prior of κh
under the alternative hypothesis H1 : κh > 0. We will refer (5.2) as a zero-inflated
inverse Gamma density, ZI-IG(·; ah , bh ).
We employ the data augmentation introduced in Dunson and Chen (2004) to
prevent MCMC samples of κh from “stuck” at zero for a long period of iterations.
Let δh = 1(κh = 0) be an indicator that equals 1 if H0 : κh = 0 holds and 0 otherwise.
Then for computational purpose, introduce latent variables κ̃h and ξ˜ih as follows:
κh = (1 − δh )κ̃h

1−δh
ξih = ξ˜ih
,

for i = 1, . . . , I,

h = 1, . . . , H + 1.

The following prior density results in the original model formulation:
π(κ̃h , ξ̃h , δh ) = IG(κ̃h ; ah , bh )

(

I
Y

)

δh
−1
1−δh
Ga(ξ˜ih ; κ̃−1
.
h , κ̃h ) π0h (1 − π0h )

i=1
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5.3

Modeling Interval-Censored Data

For interval-censored data, we need to estimate baseline cumulative hazard function
. We approximate it using a linear combination of I-splines (Cai et al, 2011):
Λ0 (t) =

K
X

γl bl (t),

(5.3)

l=1

where {bl (t)} is a set of I-splines (Ramsay, 1988), each of which is nondecreasing from
0 to 1, and {γl } is a set of nonnegative coefficients. So Λ0 (t) is nondecreasing.
Let (Lij , Rij ] denote the observed time interval for the jth subject in the ith
cluster, then conditional on frailties, the likelihood function is: L(Λ0 , β, ξ) =
ni
I Y
Y

{F (Rij |xij , ξi )}δij1 {F (Rij |xij , ξi ) − F (Lij |xij , ξi )}δij2 {1 − F (Lij |xij , ξi )}δij3 .

i=1 j=1

We formulate the likelihood using a two-step data augmentation to facilitate
posterior computation (Lin et al., 2013). It can be shown that under our model
in (5.1), the failure time of interest Tij is equivalent to the time of the 1st occurrence of a nonhomogeneous Poisson counting process {N (t) : t > 0} with mean
n

function Λ0 (t) ξi1

QH

x

o

ijh
′
h=1 ξi,h+1 exp(xij β). Let tij1 < tij2 be two time points such

that tij1 = Rij if left-censoring, tij1 = Lij and tij2 = Rij for interval censoring, and
tij2 = Lij for right-censoring, we introduce two independent latent variables: Zij =
n

N (tij1 ) ∼ Poi(Λ0 (ti j1) ξi1
n

Poi((Λ0 (tij2 ) − Λ0 (tij1 )) ξi1

QH

x

o

ijh
′
h=1 ξi,h+1 exp(xij β)) and Wij = N (tij2 ) − N (tij1 ) ∼

QH

x

o

ijh
′
h=1 ξi,h+1 exp(xij β)).

Based on the additive property of Poisson distribution and the form of Λ0 (t) in
(5.3), we further decompose as follows: Zij =

PK

l=1

Zijl , Wij =

and Wijl ’s are mutually independent, Zijl ∼ Poi(γl bl (tij1 )ξi1
Wijl ∼ Poi((γl bl (tij2 ) − γl bl (tij1 ))ξi1
δij1 = 1,

PK

l=1

0 if δij3 = 1.

Zijl = 0 and

PK

l=1

nQ
H

x

o

nQ
H
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PK

l=1

l=1

xijh
h=1 ξi,h+1

ijh
′
h=1 ξi,h+1 exp(x β)), with

Wijl > 0 if δij2 = 1, and

PK

o

PK

l=1

Zijl = 0 and

Wijl , Zijl ’s,
exp(x′ij β)),
Zijl > 0 if
PK

l=1

Wijl =

Then the augmented data likelihood is:
Laug =

ni
I Y
Y

i=1 j=1

(K
Y

δij2 +δij3

Poi(Zijl )Poi(Wijl )

l=1

)

(5.4)

{1(Zij > 0)}δij1 {1(Zij = 0)}δij2 {1(Wij > 0)}δij2 {1(Zij = 0)}δij3 {1(Wij = 0)}δij3
5.4

Gibbs Sampling Algorithm

Based on the augmented data likelihood (5.4), we can derive the full conditional
distributions for our parameters. The Gibbs sampler for posterior computation can
be outlined as the following three parts: i) updating Poisson latent variables Zij ’s,
Zijl ’s, Wij ’s, and Wijl ’s; ii) updating the parameters related to baseline cumulative
hazard Λ0 (t) ; iii) updating the regression coefficient parameters; iv) updating δ, κ,
and ξ using the data augmentation algorithm in section 5.2.
For Poisson latent variables, at each iteration, first set Zij ’s, Zijl ’s, Wij ’s, and
Wijl ’s all equal to zero, then:
• If δij1 = 1, then sample
Zij ∼ Poi(Λ0 (Rij )ξi1

(

H
Y

xijh
ξi,h+1

h=1

)

(Zij1 , . . . , ZijK ) ∼ Multinomial(Zij , pij ),

exp(β ′ xij ))1(Zij > 0),

pij ∝ (γ1 b1 (Rij ), . . . , γK bK (Rij )).

• If δij2 = 1, then sample
W ij ∼ Poi((Λ0 (Rij ) − Λ0 (Lij ))ξi1

(

H
Y

h=1

xijh
ξi,h+1

)

exp(β ′ xij ))1(Wij > 0),

(Wij1 , . . . , WijK ) ∼ Multinomial(Wij , qij ),
qij ∝ (γ1 (b1 (Rij ) − b1 (Lij )), . . . , γK (bK (Rij ) − bK (Lij ))).
For the coefficient γl involved in approximating baseline cumulative hazard Λ0 (t),
we assign a prior γl ∼ exp(η) and a hyperprior η ∼ Ga(aη , bη ). Then we got the
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conjugate full conditional density:
γl |· ∼ Ga(1 +

ni
I X
X

(Zijl δij1 + Wijl δij2 ),

i=1 j=1

η+

ni
I X
X

ξi1

i=1 j=1

(

H
Y

xijh
ξi,h+1

h=1

)

exp(β ′ xij )(bl (Rij )(δij1 + δij2 ) + bl (Lij )δij3 ))

For sampling of regression parameters βr , r = 1, . . . , p, since all our covariates are
binary in this project, we define parameter ωr = eβr , r = 1, . . . , p, which makes the
regression term: exp(x′ij β) =

Qp

x

r=1

ωr ijr . By specifying a Gamma prior ωr ∼ Ga(c, d),

we get conjugate gamma full conditional distributions for the parameters ωr :
ωr |· ∼ Ga(c +

ni
I X
X

xijr (Zij δij1 + Wij2 δij2 ),

i=1 j=1

d+

ni
I X
X

xijr (

i=1 j=1

Y

x

ωl ijl )(ξi1

H
Y

x

ijh
ξi,h+1
)(Λ0 (Rij )δij1 + Λ0 (Rij )δij2 + Λ0 (Lij )δij3 ))

h=1

l6=r

Step iv) of our Gibbs sampling algorithm is a little complicated and iterates
through the following substeps:
(1) Sample δh , h = 1, . . . , H, from Bernoulli(π̃h ), where
π̃h =

π0h L(Λ0 , β, ξh ≡ 1, ξ(−h) )
,
π0h L(Λ0 , β, ξh ≡ 1, ξ(−h) ) + (1 − π0h )L(Λ0 , β, ξh = ξ̃h , ξ(−h) )

with ξ(−h) denotes all frailties except for the hth.
(2) Sample κ̃h , h = 1, . . . , H + 1, from its full conditional distribution using adaptive
rejection Metropolis sampling (ARMS) algorithm (Gilks et al., 1995):
κ̃h |· ∝

(

−1
κ̃−1
h ∗ ∗κ̃h
Γ(κ̃−1
h )

)I

"

exp −κ̃−1
h

( I
X
i=1

ξ˜ih −

I
X
i=1

log(ξ˜ih ) + bh

)#

ah −1
(κ̃−1
.
h )

(3) Sample ξ˜i1 , i = 1, . . . , I from
Ga(κ̃1 + (1 − δ1 )

ni
X

(Zij δij1 + Wij δij2 ),

j=1

κ̃−1
1

+ (1 − δ1 )

ni
X

′

x

x

ijH
exij β ξi2ij1 . . . ξi,H+1
) {Λ0 (Rij )(δij1 + δij2 ) + Λ0 (Lij )δij3 } .

j=1
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(4) For each h = 2, . . . , H + 1, sample ξ˜ih , i = 1, . . . , I, from
Ga(κ̃−1
h + (1 − δ)
κ̃−1
h +

ni
X

j=1



ni
X

xij1 (Zij δij1 + Wij δij2 ),

j=1
x′ij β

ξi1 e

(

Y

l6=h



x

ijl
ξi,l+1
) {0 (Rij )(δij1 + δij2 ) + Λ0 (Lij )δij3 } (1 − δh )xij,h−1 ).

For each frailty, we record the estimated probability of homogeneity for at each
(s)

iteration as π̃h . Then we can estimate the posterior probability of homogeneity using
the average over all iterations:
π̂h =

S
1X
(s)
π̃ ,
S s=1 h

h = 1, . . . , H + 1.

Then we can calculate the corresponding Bayes factor of homogeneity for each frailty
on the basis of posterior probabilities of indicators (δh ,
BFh =

P r(δh = 1|L, R, x)/P r(δh = 1)
,
P r(δh = 0|L, R, x)/P r(δh = 0)

h = 1, . . . , 3):

h = 1, . . . , H + 1,

where P r(δh = 1) denotes the prior probability of homogeneity of the hth frailty and
P r(δh = 1|L, R, x) denotes the correponding posterior probability of homogeneity.
Because we assume that the prior probabilities of homogeneity and heterogeneity are
equal (i.e., 0.5), the Bayes factor reduces to:
BFh =

P r(δh = 1|L, R, x)
Pr(δh = 0|L, R, x)

.

5.5

A Simulation Study

Our simulation study is conceptualized under a typical multi-center randomized clinical trial setting. We are interested in examine institutional variation in baseline
hazard and covariate effects. Suppose there are I = 25 institutions, each has recruited ni = 20 patients. There are two binary predictors x1 (treatment effect) and
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x2 . Suppose there is institutional variation of x1 effect only, then we generated data
from the following model:
x

x

λij (t|xij ) = λ0 (t)ξi1 ξi2ij1 ξi3ij2 exp(β1 xij1 + β2 xij2 ),

(5.5)

where ξi1 ≡ 1 (no heterogeneity in baseline risk), ξi2 ∼ Ga(2, 2) (treatment-institution
interaction), and ξi3 ≡ 1 (no heterogeneity among the x2 effect). We set Λ0 (t) =
log(1 + t), β1 = β2 = 1, and generated xij1 ∼ Bernoulli(0.5), xij2 ∼ Bernoulli(0.5).
Since we want to test whether a frailty term exists or not, we would pretend that
we do not know that ξi1 ≡ 1 and ξi3 ≡ 1. Ideally, we would expect our model to
produce a high probability that the variances κ1 and κ3 for the first and third frailties
are from the zero point mass, and a low probability that the variance κ2 for the second
frailty is from the zero point mass.
For the heterogeneity structure, we chose prior of κh ∼ ZI-IG(π0h , ah , bh ), with
π0h = 0.5, ah = 0.001, bh = 0.001, for h = 1, 2, 3. For exponentiated regression
coefficient ωr , we chose prior ωr ∼ Ga(3, 1). For coefficients γl , we chose γl ∼ exp(η),
with mean η1 , and hyperprior η ∼ Ga(1, 1). We generated a total of 100 datasets. For
each dataset, we run a total of 13,000 iterations, with the first 3000 discarded as a
burn-in. The simulation results are summarized over the 100 datasets.
We evaluated the convergence of the MCMC chains for our model parameters with
traceplot and the Geweke’s convergence diagnostic. Here we present the diagnostics
for our first simulated dataset. Figures 5.1 to Figure 5.5 are the traceplots for β1 ,
β2 , π1 , π2 , and π3 . The chains seem to mix well. Table 5.1 contains the z-scores and
the correspoinding p-values from the Geweke’s test. Since all the p-values are greater
than 0.05, it is reasonable to say that the chains have converged to their stationary
distributions.
Table 5.2 lists the posterior probability of homogeneity for each frailty and the
related Bayes factors. Kass and Raftery (1995) suggests the cutoff points for positive,
strong, and very strong evidence for a Bayes factor as: 3, 20, and 150. The Bayes
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Figure 5.1 Traceplot of fixed effect β1 in simulation study.
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Figure 5.2 Traceplot of fixed effect β2 in simulation study.
factor in support of homogeneity for the first frailty is 30, which is a strong evidence
that there is no institutional variation in baseline risk. For the second frailty, the
Bayes factor for homogeneity is less than 1, so we calculated the Bayes factor for
heterogeneity as (1 − 0.017)/0.017 = 59 > 20, so we have strong evidence that the
effect of covariate x1 varies across institutions. Finally, for the third frailty, the Bayes
factor for homogeneity is 14 > 3, which provides a positive evidence that the effect
of covariate x2 does not have institutional variation.
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Figure 5.3 Traceplot of the probability of homogeneity for ξi1 in simulation study.
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Figure 5.4 Traceplot of the probability of homogeneity for ξi2 in simulation study.
Since there are three potential frailties in the model, then based on the absence/presence of each frailty, there can be 8 possible models. Each model corresponds to one combination of the three homogeneity indicators δ1 , δ2 , and δ3 . Table
5.3 lists the posterior probability of each model with corresponding combination of
δ’s. The models are listed in the order of estimated posterior probabilities from
high to low. Our true model is the one with only the second frailty exists, i.e.,
(δ1 , δ2 , δ3 ) = (1, 0, 1). Our analysis correctly places a high probability (0.8729) on
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Figure 5.5 Traceplot of the probability of homogeneity for ξi3 in simulation study.
Table 5.1 Geweke’s convergence diagnostic for MCMC chains of the model
parameters in the 1st simulated dataset
Paramter Z-score p-value

β1

-1.5372

0.8724

β2

-0.5737

0.4862

π1

-0.9982

0.3182

π2

1

0.3173

π3

-0.7091

0.4783

this model.The other models all have very low estimated posterior probabilities.
In addition to the selection of frailties, our approach produces model-averaged
inference on the fixed effects of covariates after accounting for uncertainty in the
frailty selection process (Table 5.4). The point estimates for β1 and β2 are very
close to the true values of 1. And the 95% coverage probabilities are close to the
nominal level.
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Table 5.2 Posterior homogeneity probabilities and Bayes factors of frailties in the
simulation study
Paramter

Estimate

Bayes factor

π1 = Pr(H01 |data)

0.968

30

π2 = Pr(H02 |data)

0.017

<1

π3 = Pr(H03 |data)

0.933

14

Table 5.3 Posterior probabilities of the 8 possible models in the simulation study
Model
(δ1 , δ2 , δ3 )

1
(1,0,1)

2
(1,0,0)

3
(0,0,1)

4
(1,1,1)

5
(0,1,1)

6
(0,0,0)

7
(1,1,0)

8
(0,1,0)

Probability

0.8729

0.0648

0.0370

0.0093

0.0088

0.0035

0.0020

0.0019

Table 5.4 Estimated fixed effects and coverage probabilities in the simulation study
Paramter Estimate

5.6

Bias

95%C.P.

β1 (1)

1.02

0.02

0.95

β2 (1)

1.03

0.03

0.98

Lymphatic Filariasis Example

Lymphatic filariasis is a parasitic disease caused my microscopic, thread-like worms.
It is spread from person to person by mosquitoes. The adult worms live in human
lymph system in the form of nests. Their characteristic movement called "filarial
dance sign" can be detected by ultrasound. When all the worms in a nest are killed
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by antifilarial drugs, the filarial dance sign ceases. A randomized clinical trial was conducted in Recife, Bazil (Dreyer et al., 2006) to compare the effect of co-administration
of diethylcarbamazine and albendazole (DEC/ALB) (new treatment) against DEC
alone (standard treatment). Among the 47 patients, 22 were randomized to the
DEC/ALB treatment arm (x1 = 0) and 25 to the DEC (x1 = 1) treatment arm.
During the one-year follow-up period, ultrasound examinations were performed at 7,
14, 30, 45, 60, 90, 180, 270, and 360 days after drug administration. The outcome of
interest is the nest-specific time of clearance of all its worms. So the data is intervalcensored and each patient forms a cluster with cluster size being the number of nests
of adult filial worms residing in this patient.
This data has been analyzed by Williamson et al. (2008), Zhang and Sun (2010),
and Kim (2010) using different modeling methods. Their analysis results suggest that
the time-to-clearance of a nest depends on the number of nests in the corresponding
patient. So in addition to the main variable of interest: the treatment effect (x1 ),
we also defined another covariate x2 = 1 if cluster size > 1, and 0 otherwise. There
are 23 patients with 1 nest each, 20 patients with 2 nests, 2 patients with 3 nests,
1 patient with 4 nests, and another 1 patient with 5 nests. We want to investigate
whether there is any patient-wise variation of baseline hazard, treatment effect, or
cluster size effect. Also, we are interested in evaluating the fixed effect (within-cluster
effect) of treatment and cluster size. Consider the multivariate frailty model of the
form (5.5). We let π0h = 0.5, ah = 1, bh = 1, for h = 1, 2, 3; ωr ∼ Ga(1, 1); and
η ∼ Ga(1, 1). The MCMC algorithm was carried out through 11000 iterations with
the first 1000 as a burn-in.
We assessed the MCMC chains for our model parameters with traceplot and
Geweke’s convergence diagnostic. Figure 5.6 to Figure 5.10 are the traceplots for
model parameters, we can see that the chains are well mixed and are stable. Table
5.5 shows the Geweke’s diagnostic for the chains of our model parameters: fixed ef-

71

fects β1 , β2 , and frailty homogeneity indicator π1 , π2 , π3 . As we can see, the p-values
are all greater than 0.05. By looking at the traceplots and the p-values, we have
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confidence that the MCMC chains have converged.
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Figure 5.6 Traceplot of fixed effect β1 in lymphatic filariasis study.
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Figure 5.7 Traceplot of fixed effect β2 in lymphatic filariasis study.

Table 5.6 shows the posterior probability of homogeneity for each of our three
frailties and the corresponding Bayes factor. According to the Bayes factor scale
suggested by Kass and Raftery (1995), we have very strong evidence (BF > 150) of
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Figure 5.8 Traceplot of the probability of homogeneity for ξi1 in lymphatic
filariasis study.
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Figure 5.9 Traceplot of the probability of homogeneity for ξi2 in lymphatic
filariasis study.
patient-wise variation in baseline hazard function, and strong evidence (BF > 20) of
homogeneity in treatment effect and cluster size effect across patients.
Table 5.7 shows the posterior probability for each of the 8 possible models based
on the absence/presence of the 3 potential frailties. The models are listed in the
order of high posterior probability to low posterior probability. There is a very
high probability (0.9595) for model 1, which specifies that there exists a frailty for
73

1.0
0.8
0.6
0.4
0.2
0.0
0

2000

4000

6000

8000

10000

iteration

Figure 5.10 Traceplot of the probability of homogeneity for ξi3 in lymphatic
filariasis study.
Table 5.5 Geweke’s convergence diagnostic for MCMC chains of model parameters
in the lymphatic filariasis study
Paramter Z-score p-value

β1

-0.9598

0.3372

β2

0.7836

0.4333

π1

0.876

0.3810

π2

-0.7706

0.4409

π3

-1.248

0.2120

baseline hazard but no frailty for either treatment effect or cluster size. The estimated
posterior probabilities for all the other models are very low. As expected, this model
selection result agrees closely with the frailty selection result.
Table 5.8 presents the model-averaged estimation for fixed effects of treatment
and cluster size. The estimate for treatment effect (β̂1 = 0.536) agrees with the one
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(β̂1 = 0.585, p-value = 0.089) from Williamson et al. (2008). Although the influence
of cluster size is insignificant too, the negative sign implies possibly slower elimination
in a patient with multiple nests. This agrees with the previous studies.
Table 5.6 Posterior homogeneity probabilities and Bayes factors of frailties in the
lymphatic filariasis study
Paramter

Estimate

Bayes factor

π1 = Pr(H01 |data)

6e-18

<1

π2 = Pr(H02 |data)

0.981

49

π3 = Pr(H03 |data)

0.977

49

Table 5.7 Posterior probabilities of the 8 possible models in the lymphatic filariasis
study
Model
(δ1 , δ2 , δ3 )

1
(0,1,1)

2
(0,1,0)

3
(0,0,1)

4
(0,0,0)

5
(1,1,1)

6
(1,1,0)

7
(1,0,1)

8
(1,0,0)

Probability

0.9595

0.0211

0.0186

0.0008

0.0000

0.0000

0.0000

0.0000

Table 5.8 Estimated fixed effects and 95% CIs in the lymphatic filariasis study
Parameter

Estimate

95%C.I.

Treatment

0.516

(-0.58, 1.48)

Cluster size

-0.785

(-2.05, 0.52)
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Chapter 6
Conclusions
In this dissertation, we have developed an R package for modeling case 1 or general interval-cenosred data under the PH, PO, or probit models, a PH model with
spatial random effect for spatially correlated interval-censored data, and a multivariate frailty PH model for clustered interval-censored data. Methodology and software
development for interval-censored data are important for many medical studies in
practice (e.g., infection, AIDS, and oncology clinical trials). They would allow for
more accurate estimation of treatment effect while accounting for interval-censorship.
For all of the three projects, our nonparametric formulation of a monotonic spline
provides more flexible approximation for baseline cumulative hazard function compared to parametric assumptions. Data augmentation makes the MCMC sampling
straightforward to implement compared to other methods in the literature. In the
following, we conclude the three projects respectively.
In the first project, we first review the methods and software available for analyzing interval-censored data. Considering the lack of very useful software for fitting
regression models for such data, we aim to provide a comprehensive package which
implement several popular survival regression models under Bayesian framework. We
provide inference for regression coefficients and smooth estimation for both baseline
survival curves and particular survival curves based on user-specified covariate(s).
The package is straightforward to use, as a user only needs to provide interval endpoints, covariates, censoring indicator, knots for I-splines, and grids for survival estimation. On the other hand, it is also flexible, as a user can adjust model fitting
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through multiple arguments based on her/his prior knowledge about the data. Furthermore, MCMC chains for critical parameters can be saved for later convergence
diagnosis. Our package is still under development. For example, one future plan
is to include extra functions to analyze clustered interval-censored data and spatial
interval-censored data.
For the second project, we developed an efficient semiparametric method under the
PH model to deal with spatially correlated general interval-censored data. To account
for our assumption that subjects within an area are correlated and the random effect
for an area depends on the random effects of its neighbors, we employ the conditional
autoregressive model that is commonly used in spatial statistics for lattice data.
The capture of spatial heterogeneity and clustering by structured random effects
reduces estimation biases for regression parameters that are often of main interest.
An area of future work is to evaluate the robustness of spatial random effects to
violation of normality assumption. One may need to consider nonparametric priors
to relax the normality assumption if spatial random effects are sensitive to model
misspecification. Also, one may incorporate the more general spatial random effects
to allow for potential variation of the effects of predictors across areas. In addition,
the proposed model can be extended to accommodate spatial and temporal data.
In the third project, we propose a Bayesian approach for inferences on clustered
interval-censored failure time data. We generalize the commonly used shared frailty
model for interval-censored data to include multiple frailties to account for clusterwise variation of covariate effects. Furthermore, our method allows for frailty selection
by estimating the posterior probability of a frailty and calculating the related Bayes
factor. After accounting for uncertainty in frailty selection and random effects, the
inference for proportional hazards fixed regression coefficients are less prone to bias.
The proposed Gibbs sampler algorithm has been proved to be efficient and have good
performance through our simulation study and real data analysis. This approach is
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especially useful in multi-center clinical trials for cancer or infectious diseases, since
the detection of cancer progression or infection is normally made through periodic lab
examinations. Since current literature for clustered interval-censored data are mainly
involving shared-frailty models, our developed model is a meaningful extension to the
methodology for this type of data. The future research may focus on incorporating
nonparametric modeling for frailties with selection, while allowing for nonparametric
modeling for the hazard function.
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